The University of Western Ontario

Adams, P.C. 1998. Factors affecting rate of iron mobilization during venesection therapy for hereditary hemochromatosis. American Journal of Hematology 58: 16-19.

Adams, P.C. 1998. Hepatitis and the physician Hepatology Update 1997. Canadian Journal of Gastroenterology 12: 17-20.

Adams, P.C. 1998. Implications of genotyping of spouses to limit investigation in children in genetic hemochromatosis. Clinical Genetics 53: 176-178.

Adams, P.C. 1997. Inherited Liver Disease. First Principles of Gastroenterology. 3rd ed. A.B.R. Thompson, and E.A. Shaffer. Edmonton, AB: Canadian Association of Gastroenterology. 512-514.

Adams, P.C. 1998. Iron overload in alcoholic and viral liver disease. Journal of Hepatology 28: 19-20.

Adams, P.C. 1997. Traffic jam for the hemochromatosis mutant protein. Hepatology 26: 1684.

Adams, P.C., C. Bradley, and A.R. Henderson. 1997. Evaluation of the hepatic iron index as a diagnostic criterion in genetic hemochromatosis. Journal of Laboratory and Clinical Medicine 130: 509-514.

Adams, P.C., and S. Chakrabarti. 1998. Genotypic/phenotypic correlation in genetic hemochromatosis: Evolution of diagnostic criteria. Gastroenterology 114: 319-323.

Burke, W., E. Thomson, M. Khoury, S. McDonnell, N. Press, P.C. Adams, J. Barton, E. Beutler, G. Brittenham, A. Buchanan, E. Clayton, M. Cogswell, W. Meslin, A. Motulsky, L.W. Powell, E. Sigal, B. Wilfond, and F. Collins. 1998. Hemochromatosis: Gene discovery and its implications for population based screening. JAMA 280: 172-178.

Levstik, M., and P.C. Adams. 1998. Eligibility and exclusion of hemochromatosis patients as voluntary blood donors. Canadian Journal of Gastroenterology 12: 61-63.

Almond, D.G. 1998. Managing the patient with a stent. Perspectives in Cardiology 14: 35-44.

Almond, D.G., et al, and The Cardiac Care Network of Ontario Expert Panel on Intracoronary Stents. 1997. Public policy and coronary stenting: Report of an expert panel to the Cardiac Care Network of Ontario. Canadian Journal of Cardiology 13: 731.

Arnold, J.M.O. 1998. CARE trial: Great benefits from pravastatin in post-MI patients. Kommunicom Publications:

Arnold, J.M.O. 1998. Felodipine in addition to enalapril did not improve clinical status, functional capacity or ventricular function in patients with CHF. Evidence-Based Cardiovascular Medicine 2: 18.

Arnold, J.M.O., and M.L. Lambert. 1997. In vivo venous smooth muscle constriction is not abnormal in CHF patient. Canadian Journal of Cardiology 13: 97C.

Bailey, D.G., J.M.O. Arnold, and J.D. Spence. 1998. Grapefruit juice: Drug interactions. British Journal of Clinical Pharmacology 46: 101-110.

Bailey, D.G., J.M.O. Arnold, and J.D. Spence. 1998. Grapefruit juice-drug interactions (Review). British Journal of Clinical Pharmacology 45: 101-110.

Callow, I.D., P. Campisi, M.L. Lambert, Q. Feng, and J.M.O. Arnold. 1998. Enhanced in vivo a1- and a2- adrenoceptor-mediated venoconstriction with indormethacin in humans. American Journal of Physiology 275: H837-H843.

Feng, Q., X.R. Lu, A.J. Fortin, A. Pettersson, T. Hedner, R.L. Kline, and J.M.O. Arnold. 1998. Elevation of an endogenous inhibitor of nitric oxide synthase in experitmental congestive heart failure. Cardiovascular Research 37: 667-675.

Gupta, A., and J.M.O. Arnold. 1998. Does this patient have congestive heart failure? Canadian Journal of Diagnosis 15: 95-107.

Pitt, B., R. Segal, F.A. Martinez, G. Meurers, A.J. Cowley, I. Thomas, P.C. Deedwania, D.E. Ney, D.B. Snavely, P.I. Chang, J.M.O. Arnold, and The ELITE Study Investigators. 1997. Randomised trial of losartan versus captopril in patients over 65 with heart failure. Lancet 349: 747-752.

St. John Sutton, M., M.A. Pfeffer, L. Moye, T. Plappert, J.-L. Rouleau, G. Lamas, J. Rouleau, J.O. Parker, J.M.O. Arnold, B. Sussex, E. Braunwald, and The SAVE Investigators. 1997. Cardiovascular death and left ventricular remodelling two years after myocardial. Circulation 96: 3294-3299.

Tsuyuki, R.T., S. Yusuf, J.L. Rouleau, J.M.O. Arnold, et al, and The RESOLVD Pilot Study Investigators. 1997. Combination neurohormonal blockade with ACE inhibitors, angiotensin II antagonists and beta-blockers in patients with congestive heart failure: Design of the randomized evaluation of strategies for left ventricular dysfunction. Canadian Journal of Cardiology 13: 1166-1174.

Couroux, P.R., Z. Hussain, F.S. Rutledge, R. Lannigan, E.D. Ralph, B. Nancekivell, and T.W. Austin. 1997. Polymerase chain reaction and RNA hybridization-based method for the investigation of deep-seated candidiasis. Canadian Journal of Infectious Diseases 8: 329-334.

Bailey, D.G., J.M.O. Arnold, and J.D. Spence. 1998. Grapefruit juice: Drug interactions. British Journal of Clinical Pharmacology 46: 101-110.

Bailey, D.G., J.M.O. Arnold, and J.D. Spence. 1998. Grapefruit juice-drug interactions (Review). British Journal of Clinical Pharmacology 45: 101-110.

Bailey, D.G., J.H. Kreeft, C. Munoz, J.D. Freeman, and J.R. Bend. 1998. Grapefruit juice-felodipine interaction: effect of naringin and 6', 7'-dihydroxybergamottin in humans. Clinical Pharmacology & Therapeutics 64: 248-256.

Lown, K.S., D.G. Bailey, R.J. Fontana, S.K. Janardan, C.H. Adair, L.A. Fortlage, M.B. Brown, W. Guo, and P.B. Watkins. 1997. Grapefruit juice increases felodipine oral availability in man by decreasing intestinal CYP3A4 protein expression. Journal of Clinical Investigation 99: 2545-2554.

Behme, M.T. 1997. Symposium on Diet, Nutrition and Health: An Update. Nutrition Today 32: 23-29.

Guan, J., P. Atkinson, M.T. Behme, J. Dupre, P. Zucker, and R. Zhong. 1998. Insulin sensitivity and glucose turnover in rats with pancreas islet transplants. Diabetes 47: 1020-1026.

Mahmoudi, M., J.Y. Edwards, D.A. Bell, and E. Cairns. 1997. V region analysis of human hybridoma monoclonal anti-Sm antibodies. Lupus 6: 578-590.

Nielson, W.R., M. Harth, and D.A. Bell. 1997. Out-Patient cognitive-behavioural treatment of fibromyalgia: Impact on pain response and health status. Pain Research Management 2: 145-150.

Pope, J., A. Stevens, W. Howson, and D.A. Bell. 1998. The development of RA following recombinant Hepatitis B vaccination. Journal of Rheumatology 25: 1687-1693.

Bellamy, N. 1998. Design of clinical trials for evaluation of disease-modifying osteoarthritis drugs (DMOADs) and of new agents for symptomatic treatment of osteoarthritis. Osteoarthritis. K. Brandt, M. Doherty, and S. Lohmander. Oxford: Oxford University Press. 531-542.

Bellamy, N. 1997. Osteoarthritis. Bailliere Tindall 11: 4.

Bellamy, N. 1998. Practical problem chapter 812K - Assessment of prognosis and outcome in osteoarthritis. Rheumatology, Volume 2. 2nd ed. J.H. Klippel, and P.A. Dieppe. London: Mosby-Wolfe. 12.15-12.16.

Bellamy, N. 1998. Principles of outcome assessment. Rheumatology, Volume 1. J.H. Klippel, and P.A. Dieppe. London: Mosby-Wolfe. 14.1-14.10.

Bellamy, N., C. Bachmeier, P.M. Brooks, C.D. Browns, M.L. Cohen, L. March, P.G. Conaghan, R.O. Day, and J. Campbell. 1997. Ostoearthritis antirheumatic drug trials: Effects of a standardized instructional videotape on the reliability of observer-dependent outcome measures. Inflammopharmacology 5: 285-295.

Bellamy, N., J. Campbell, J. Stevens, L. Pilch, C. Stewart, and Z. Mahmood. 1997. Validation study of a computerized version of the Western Ontario and McMaster Universities VA30 Osteoarthritis Index. Journal of Rheumatology 24: 2413-2415.

Bellamy, N., D.L. Duffy, P. Sambrook, R.R.C. Buchanan, P.M. Brooks, H. Dunckley, S.C. Healey, S. Mason, and N.G. Martin. 1998. A methodological appraisal of the impact of different classification procedures used in the Australian Rheumatoid Arthritis Twin Survey. Inflammopharmacology 6: 81-89.

Bellamy, N., S. Kaloni, J. Pope, W.K. Coulter, and J. Campbell. 1998. Quantitative rheumatology: A survey of outcome measurement procedures in routine rheumatology outpatient practice in Canada. Journal of Rheumatology 25: 852-858.

van der Heijde, D., N. Bellamy, A. Calin, M. Dougados, M.A. Khan, S. van der Linden, and The ASAS Working Group. 1997. Preliminary core sets for endpoints in ankylosing spondylitis. Journal of Rheumatology 24: 2225-2229.

Bailey, D.G., J.H. Kreeft, C. Munoz, J.D. Freeman, and J.R. Bend. 1998. Grapefruit juice-felodipine interaction: effect of naringin and 6', 7'-dihydroxybergamottin in humans. Clinical Pharmacology & Therapeutics 64: 248-256.

Blake, P.G. 1999. Adequacy of Peritoneal Dialysis. Therapy in Nephrology and Hypertension. H.R. Brady, and C.S. Wilcox. W.B. Saunders Company. 589-597.

Blake, P.G. 1998. Is peritoneal dialysis gaining ground in North America? Contemporary Dialysis & Nephrology (February): 23-25.

Blake, P.G. 1997. The problem of mathematical coupling: How can statistical artifact and biological causation be separated when relating protein intake to clearance in 'pre-dialysis' and dialysis patients? Peritoneal Dialysis International 17: 431-434.

Blake, P.G. 1998. A review of the "DOQI" recommendations for peritoneal dialysis. Peritoneal Dialysis International 18: 247-251.

Lindsay, R.M., P.G. Blake, P. Malek, G. Posen, B. Martin, and E. Bradfield. 1998. The accuracy and precision of access recirculation measurements by the hemodynamic recirculation monitor. American Journal of Kidney Diseases 31: 242-249.

Lindsay, R.M., P.G. Blake, P. Malek, G. Posen, B. Martin, and E. Bradfield. 1997. Hemodialysis access blood flow rates can be measured by a differential conductivity technique and are predictive of access clotting. American Journal of Kidney Diseases 30: 475-482.

Lindsay, R.M., E. Bradfield, C. Rothera, C. Kianfar, P. Malek, and P.G. Blake. 1998. A comparison of methods for the measurement of hemodialysis access recirculation and access blood flow rate. ASAIO 44: 62-67.

Borrie, M.J., and A. Saltmarch. 1998. Introduction. Ostomy/Wound Management 44 (6): 26.

Boughner, D.R. 1998. Pre-stroke management: Tips from a cardiologist. Perspectives in Cardiology 14: 29-41.

Boughner, D.R., J. Dunmore-Buyze, N. Macris, and I. Vesely. 1998. A comparison of macroscopic lipd content within porcine, pulmonary and aortic valves: Implications for bioprosthetic valves. Journal of Thoracic and Cardiovascular Surgery 115: 260-261.

Duncan, A.C., and D.R. Boughner. 1998. Effect of dynamic glutaraldehyde fixation on the viscoelastic properties of bovine pericardial tissue. Biomaterials 19: 777-783.

Duncan, A.C., D.R. Boughner, and I. Vesely. 1997. Viscoelasticity of dynamically fixed bioprosthetic valves: II Effect of glutaraldehyde concentration. Journal of Thoracic and Cardiovascular Surgery 114: 513.

Boyd, D.B. 1998. Chronic Fatigue Syndrome. Therapeutic Choices. 2nd ed. 786-790.

Kovacs, M.J., K. Weir, K. MacKinnon, M. Keeney, W.F. Brien, and M.K. Cruickshank. 1998. Body weight does not predict for anti-Xa levels after fixed dose prophylaxis with Enoxaparin after orthopedic surgery. Thrombosis Research 91: 137-142.

Larocque, B.J., K. Gilbert, and W.F. Brien. 1997. A Point Score System to Predict the Likelihood of Blood Transfusion Following Hip of Knee Arthroplasty. Transfusion 37: 463-467.

Larocque, B.J., K. Gilbert, and W.F. Brien. 1998. Prospective Validation of a Point Score System for Predicting Blood Transfusion Following Hip and Knee Replacement. Transfusion 38: 932-937.

Leclerc, J.R., M. Gent, J. Hirsh, W.F. Brien, J. Ginsberg, M.K. Cruickshank, and The Canadian Collaborative Group. 1998. The incidence of symptomatic venous thromboembolism during and after prophylaxis with enoxaparin. Archives of Internal Medicine 158: 873-878.

Badner, N.H., R.L. Knill, J.E. Brown, T.V. Novick, and A.W. Gelb. 1998. Myocardial infarction after noncardiac surgery. Anesthesiology 88: 572-578.

Ostbye, T., C. Pause, O. Meissner, B.G. Feagan, J.E. Brown, H.R. Strasberg, and J. Dodge. 1998. Learning About Clinical Trials - The Western Multicentre, Randomized, Double-blind, Placebo-controlled Clinical Trial on the Effect of Caffeine on Alertness and Cardiovascular Parameters. Medical Teacher 20: 127-132.

Brymer, C., C. Cormack, and K.A. Spezowka. 1998. Improving care of the elderly in rural communities through education. Gerontology and Geriatrics Education 19: 27-36.

Mahmoudi, M., J.Y. Edwards, D.A. Bell, and E. Cairns. 1997. V region analysis of human hybridoma monoclonal anti-Sm antibodies. Lupus 6: 578-590.

Hansson, L., A. Zanchetti, S.G. Carruthers, B. Dahlof, D. Elmfeldt, S. Julius, J. Menard, K.H. Rahn, H. Wedel, and S. Westerling. 1998. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with. The Lancet 351: 1755-1762.

Hansson, L., A. Zanchetti, S.G. Carruthers, and The HOT Study Group. 1997. 24-month data on blood pressure and tolerability. Blood Pressure 6: 313-317.

Sunstrom, C.A., P. Carruthers-Czyzewski, S.G. Carruthers, P. Larochelle, W. McLean, P.T. Pollak, and P. Jewesson. 1997. The difficulty in assessing the relative therapeutic merit of new antineoplastic drugs. Canadian Journal of Clinical Pharmacology 4: 118-125.

Chin-Yee, I.H., L. Anderson, M. Keeney, D.R. Sutherland, and The Canadian QASE Study Group. 1997. Quality assurance of stem cell enumeration by flow cytometry. Cytometry (Communications in Clinical Cytometry) 30: 296-303.

Chin-Yee, I.H., M. Keeney, L. Anderson, G. Dietz, and G. Moses. 1998. Supernatant from stored red cell activates neutrophils. Transfusion Medicine 8: 49-56.

d'Almeida, M.S., W.J. Sibbald, M. White, and I.H. Chin-Yee. 1998. Influence of sepsis on the plasma elimination pharmokinetics of diaspirin cross-linked hemoglobin in rats. Artificial Cells, Blood Substitutes and Immobilization Biotechnology 26

Keeney, M., I.H. Chin-Yee, K. Weir, J. Popma, R. Nayar, and D.R. Sutherland. 1998. Single platform cytometric absolute CD34+ cell counts based on the ISHAGE guidelines. Cytometry (Communications in Clinical Cytometry) 34: 61-70.

Sielenkamper, A.W., I.H. Chin-Yee, C.M. Martin, and W.J. Sibbald. 1997. Diaspirin crosslinked hemoglobin improves systemic oxygen uptake in oxygen supply-dependent septic rats. American Journal of Respiratory and Critical Care Medicine 156: 1066-1072.

Sutherland, D.R., I. Anderson, M. Keeney, R. Nayar, and I.H. Chin-Yee. 1997. Towards a worldwide standard for CD34+ enumeration? (Response to Letter to the Editor). Journal of Hematology 6: 85-89.

Martino, T.A., M. Petric, M. Brown, K. Aitken, C.J. Gauntt, C.D. Richardson, L.H. Chow, and P.P. Liu. 1998. Cardiovirulent coxsackie viruses and the decay-accelerating factor (CD55) receptor. Virology 244: 302-314.

Clark, W.F., D.N. Churchill, L. Forwell, G. MacDonald, and S. Foster. 1998. To Pay or Not to Pay? - A decision and cost-utility analysis from the state perspective of ACE-inhibitor therapy for diabetic nephropathy. Annals of Internal Medicine.

Clark, W.F., and L. Moist. 1998. Management of chronic renal insufficiency in lupus nephritis: Role of proteinuria, hypertension and dyslipidemia in the progression of renal disease. Lupus.

Moist, L., G. Nesrallah, C. Kortas, E. Ispiritu, T. Ostbye, and W.F. Clark. 1998. Plasma exchange in rapidly progressive renal failure due to multiple myeloma. American Journal of Nephrology.

Bellamy, N., S. Kaloni, J. Pope, W.K. Coulter, and J. Campbell. 1998. Quantitative rheumatology: A survey of outcome measurement procedures in routine rheumatology outpatient practice in Canada. Journal of Rheumatology 25: 852-858.

Crilly, R.G., and A. Camilleri. 1998. Osteoporosis: Summary of current knowledge Part 1: Diagnosis and assessment of risk. Mature Medicine 4 (4).

Crilly, R.G., and A. Camilleri. 1998. Osteoporosis: Summary of current knowledge Part II: Prevention and treatment. Mature Medicine 1 (5).

Klosek, M., and R.G. Crilly. 1997. Leisure Competence Measure: An Introduction to Measuring Outcomes in Therapeutic Recreation.

Brigden, M.L., M.J. Johnston, The Thrombosis Interest Group of Canada, and M.K. Cruickshank. 1998. INR reporting in Canadian medical laboratories: An update. American Journal of Clinical Pathology 109: 589-594.

Kovacs, M.J., K. Weir, K. MacKinnon, M. Keeney, W.F. Brien, and M.K. Cruickshank. 1998. Body weight does not predict for anti-Xa levels after fixed dose prophylaxis with Enoxaparin after orthopedic surgery. Thrombosis Research 91: 137-142.

Leclerc, J.R., M. Gent, J. Hirsh, W.F. Brien, J. Ginsberg, M.K. Cruickshank, and The Canadian Collaborative Group. 1998. The incidence of symptomatic venous thromboembolism during and after prophylaxis with enoxaparin. Archives of Internal Medicine 158: 873-878.

Delorme, M.A., L. Xu, L. Berry, L. Mitchell, and M. Andrew. 1998. Anticoagulant dermatan sulfate proteoglycan (decorin) in the term human placenta. Thrombosis Research 90: 147-153.

Doig, G., C.M. Martin, and W.J. Sibbald. 1997. Polymyxin-dextran antiendotoxin pretreatment in an ovine model of normotensive sepsis. Critical Care Medicine 25: 1956-1961.

Edmonds, M., M. Bauer, S. Osborn, H. Lutfiyya, J.L. Mahon, G. Doig, P. Grundy, C. Gittens, G. Molenkamp, and D. Fenlon. 1998. Using the Vista 350 Telephone to Communicate the Results of Home Monitoring of Diabetes Mellitus to a Central Database and to Provide Feedback. International Journal of Medical Informatics 51: 117-125.

Izawa, J.I., M. Moussa, M.G. Cherian, G. Doig, and J.L. Chin. 1998. Metallothionein expression in renal cancer. Urology 52 (5): 767-772.

Mack, L., N. Kervliet, G. Doig, and F.P. O'Malley. 1997. Relationship oc a new histological categorization of ductal carcinoma in situ of the breast with size and immunohistochemical expression of p53, c-erb B2, bcl-2, and ki-67. Human Pathology 28: 974-979.

Randolph, A.G., G.H. Guyatt, J.E. Calvin, G. Doig, W.S. Richardson, and The Evidence Based Medicine in Critical Care Group. 1998. Understanding articles describing clinical prediction tools. Critical Care Medicine 26: 1603-1612.

Tuck, A.B., F.P. O'Malley, H. Singhal, J.F. Harris, K.S. Tonkin, Z. Saas, G. Doig, and A.F. Chambers. 1998. Osteopontin expression in a group of lymph node negative breast cancer patients. International Journal of Cancer 79 (5): 502-508.

Dresser, G., and K.B. Zarnke. 1998. http://wwwhypertension: Information Overload and Serendipity on the Net. Hypertension Canada 58.

Dupre, J., C.R. Stiller, M. Ghent, A. Donner, B. von Graffenreid, D. Heinrichs, M. Jenner, P.A. Keown, J.L. Mahon, R. Martell, C.I. Momah, G. Murphy, N.W. Rodger, and B.M. Wolfe. 1998. Clinical trials of cyclosporine in IDDM. Diabetes Care 11 (Suppl 1): 37-44.

Fantus, I.G., T.L. Delovitch, and J. Dupre. 1997. Prevention of diabetes mellitus: Goal for the 21st Century: Part 2. Canadian Journal of Diabetes Care 21: 14-21.

Guan, J., P. Atkinson, M.T. Behme, J. Dupre, P. Zucker, and R. Zhong. 1998. Insulin sensitivity and glucose turnover in rats with pancreas islet transplants. Diabetes 47: 1020-1026.

Edmonds, M., M. Bauer, S. Osborn, H. Lutfiyya, J.L. Mahon, G. Doig, P. Grundy, C. Gittens, G. Molenkamp, and D. Fenlon. 1998. Using the Vista 350 Telephone to Communicate the Results of Home Monitoring of Diabetes Mellitus to a Central Database and to Provide Feedback. International Journal of Medical Informatics 51: 117-125.

Eisenhauer, M.A. 1997. Wrist and Forearm. Emergency Medicine Concepts and Clinical Practice. 4th ed. P. Rosen, and R.M. Barkin. St. Louis: Mosby Year Book.

Stiell, I.G., G.A. Wells, K. Vandemheen, A. Laupacis, R. Brison, M.A. Eisenhauer, G.H. Greenberg, I. MacPhail, R.D. McKnight, M. Reardon, R. Verbeek, J. Worthington, and H. Lesiuk. 1997. Variation In Emergency Department Use of Cervical Spine Radiography For Alert Stable Trauma Patients. Canadian Medical Association Journal (CMAJ) 156: 1537.

Stiell, I.G., G.A. Wells, K. Vandemheen, A. Laupacis, R. Brison, M.A. Eisenhauer, G.H. Greenberg, I. MacPhail, R.D. McKnight, M. Reardon, R. Verbeek, J. Worthington, and H. Lesiuk. 1997. Variation In Emergency Department Use of Computed Tomography In Patients With Minor Head Injury. Annals of Emergency Medicine 30 (1): 14.

Feagan, B.G. 1997. Antibiotics are not Effective Therapy for Crohn's Disease. Inflammatory Bowel Disease 3: 314-317.

Feagan, B.G. 1998. Azathioprine Maintains Remission in Crohn Disease but Withdrawal Rates are Higher. ACP Journal Club 33

Feagan, B.G. 1997. Does Immunosuppressive Drug Therapy Improve Patients' Quality of Life? Proceedings, New Approaches in the Management of Inflammatory Bowel Disease: From Concept to Clinic. 21 November 1997. 23-27.

Feagan, B.G. 1997. Methotrexate Therapy for Chronic Sarcoidosis: Is the Therapeutic Index Acceptable? Editorial. Journal of Pediatrics 130: 3-4.

Feagan, B.G. 1998. Methotrexate Treatment for Crohn's Disease. Inflammatory Bowel Disease 4: 120-121.

Gregor, J.C., J.W.D. McDonald, N. Klar, R. Wall, K. Atkinson, B. Lamba, and B.G. Feagan. 1997. An evaluation of utility measurements in Crohn's disease. Inflammatory Bowel Disease 3 (4): 265-276.

Hamedani, R., R.D. Feldman, and B.G. Feagan. 1997. Drug Development in Inflammatory Bowel Disease Budesonide: A Model of Targeted Therapy? Alimentary Pharmacology and Therapeutics 11 (3): 98-107.

Hamedani, R., R.D. Feldman, and B.G. Feagan. 1997. Drug development in inflammatory bowel disease Budesonide: a model of targeted therapy. Alimentary Pharmacology and Therapeutics 11: 98-108.

Hecht, G., R.B. Sartor, B.G. Feagan, and J.P. Kraehenbuhl. 1997. Role of the Enteric Microflora in the Pathogenesis of Intestinal Inflammation and Arthritis - Discussion. Alimentary Pharmacology and Therapeutics 11: 22-23.

Madara, J., B.G. Feagan, I. Bjarnason, R.B. Sartor, and N. Broughtonsmith. 1997. Drug Development in Inflammatory Bowel Disease - Budesonide - A Model of Targeted Therapy. Alimentary Pharmacology and Therapeutics 11: 107-108.

Ostbye, T., C. Pause, O. Meissner, B.G. Feagan, J.E. Brown, H.R. Strasberg, and J. Dodge. 1998. Learning About Clinical Trials - The Western Multicentre, Randomized, Double-blind, Placebo-controlled Clinical Trial on the Effect of Caffeine on Alertness and Cardiovascular Parameters. Medical Teacher 20: 127-132.

Sartor, R.B., J. Meddings, L. Mayor, J.P. Kraehenbuhl, P. Brandtzaeg, D. Jewell, L. Bjarnason, J. Madara, and B.G. Feagan. 1997. Intestinal Permeability in Crohn's Disease - Discussion. Alimentary Pharmacology and Therapeutics 11: 53-56.

Zarnke, K.B., B.G. Feagan, J.L. Mahon, and R.D. Feldman. 1997. A Randomized Study comparing a Patient-directed Hypertension Management Strategy with usual Office-based Care. American Journal of Hypertension 10: 58-67.

Chockalingam, A., M. Bacher, N. Campbell, H. Cutler, A. Drover, R.D. Feldman, G. Fodor, J. Irvine, V. Ramsdem, R. Thivierge, and G. Tremblay. 1998. Adherence to Management of High Blood Pressure: Recommendations of the Canadian Coalition for High Blood Pressure Prevention and Control. Canadian Journal of Public Health 89: I-5-I-7.

Feldman, R.D. 1997. Angiotensin II receptor blockade: Helping to halt hypertension. Canadian Journal of Diagnosis 14: 135-140.

Feldman, R.D. 1997. G-protein function is reduced in hypertension. Hypertension 29: 422-427.

Feldman, R.D., M. Bacher, N. Campbell, A. Drover, and A. Chockalingam. 1998. Adherence to Pharmacologic Management of Hypertension. Canadian Journal of Public Health 89: I-16 I-18.

Feldman, R.D., and R. Gros. 1998. Impaired vasodilator function in hypertension: The role of alterations in receptor/G-protein coupling. Trends in Cardiovascular Medicine 8: 297-305.

Feldman, R.D., N.D. Schmidt, and K.B. Zarnke. 1998. Angiotensin-converting enzyme inhibitor-mediated regulation of vasodilator function. Canadian Journal of Cardiology 14 (Suppl D): 19D-20D.

Hamedani, R., R.D. Feldman, and B.G. Feagan. 1997. Drug Development in Inflammatory Bowel Disease Budesonide: A Model of Targeted Therapy? Alimentary Pharmacology and Therapeutics 11 (3): 98-107.

Hamedani, R., R.D. Feldman, and B.G. Feagan. 1997. Drug development in inflammatory bowel disease Budesonide: a model of targeted therapy. Alimentary Pharmacology and Therapeutics 11: 98-108.

Kandaker, M., L. Xu, R. Rahimpour, B. Gill, G. Mitchel, M.E. Devries, S.K. Sinhal, J.G. Pickering, R.D. Feldman, and D.J. Kelvin. 1998. CXCR1 and CXCR2 are rapidy down-modulated by bacterial endotoxin through a unique agonist-independent, tyrosine kinase-dependent mechanism. Journal of Immunology 161: 1930-1938.

Kong, C., B.M. Gill, R. Rahimpour, L. Xu, R.D. Feldman, Q. Xiao, T.J. McDonald, L. Taupenot, S.K. Mahata, B. Singh, O, D.T. Connor, and D.J. Kelvin. 1998. Secretoneurin and chemoattractant receptor interactions. Journal of Neuroimmunology 88: 91-98.

Zarnke, K.B., B.G. Feagan, J.L. Mahon, and R.D. Feldman. 1997. A Randomized Study comparing a Patient-directed Hypertension Management Strategy with usual Office-based Care. American Journal of Hypertension 10: 58-67.

Callow, I.D., P. Campisi, M.L. Lambert, Q. Feng, and J.M.O. Arnold. 1998. Enhanced in vivo a1- and a2- adrenoceptor-mediated venoconstriction with indormethacin in humans. American Journal of Physiology 275: H837-H843.

Feng, Q., X.R. Lu, A.J. Fortin, A. Pettersson, T. Hedner, R.L. Kline, and J.M.O. Arnold. 1998. Elevation of an endogenous inhibitor of nitric oxide synthase in experitmental congestive heart failure. Cardiovascular Research 37: 667-675.

Li, S., F.L. Hwang, Q. Feng, J. Liu, S.X. Fan, and T.M. McKenna. 1998. Over expression of protein kinase Ca inhances LPS-induced nitric oxide formation in vascular smooth muscle cells. Journal of Cellular Physiology 176: 402-411.

Ferguson, K.A. 1997. Bringing your patient a good night's sleep. Canadian Journal of Diagnosis 14: 103-111.

Ferguson, K.A. 1998. Oral appliance therapy for the management of sleep-disordered breathing. Seminars in Respiratory and Critical Care Medicine 19: 157-164.

Ferguson, K.A. 1998. While you sleep - Obstructive sleep apnea physicians resource guide. VitalAire Healthcare Guide for Physicians.

Ferguson, K.A., and C.F.P. George. 1998. A quick reference guide for clinicians. Sleep Medicine (Spring)

Keenan, S.P., K.A. Ferguson, M. Chan-Yeung, and J.A. Fleetham. 1998. Prevalence of sleep disorder breathing in a population of Canadian grainworkers. Canadian Respiratory Journal 5: 184-190.

Cairns, J.A., S.J. Connolly, R. Roberts, M. Gent, K.J.C. Finnie, and The CAMIAT Investigators. 1997. Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations: CAMIAT Canadian Amiodarone Myocardila Infarction Arrhythmia Trial Investigators. Lancet 348: 1329.

Finnie, K.J.C. 1998. The CCS 1997 Consensus Conference. 1997 Consensus Conference on the Evaluation and Management of Chronic Ischemic Heart Disease, Volume 14. Canadian Cardiovascular Society. 1C-23C.

Finnie, K.J.C., and L.J. Melendez. 1997. Backwards or forwards? Canadian Journal of Diagnosis 14: 29-30.

Finnie, K.J.C., and L.J. Melendez. 1998. Changing Relationships. Canadian Journal of Diagnosis 15: 45-46.

Finnie, K.J.C., and L.J. Melendez. 1997. How many do you see? Canadian Journal of Diagnosis 14: 31-32.

Finnie, K.J.C., and L.J. Melendez. 1997. Massaging the block. Canadian Journal of Diagnosis 14: 33-34.

Finnie, K.J.C., and L.J. Melendez. 1998. A slow pace. Canadian Journal of Diagnosis 15: 35-36.

Finnie, K.J.C., and L.J. Melendez. 1998. The Swinging Heart. Canadian Journal of Diagnosis 15: 61-62.

Melendez, L.J., and K.J.C. Finnie. 1998. Is that right? Canadian Journal of Diagnosis 15: 37-38.

Melendez, L.J., and K.J.C. Finnie. 1998. Man with chest pain. Canadian Journal of Diagnosis 15: 33-34.

Melendez, L.J., and K.J.C. Finnie. 1997. An other side story. Canadian Journal of Diagnosis 14: 31-33.

Melendez, L.J., and K.J.C. Finnie. 1997. Perioperative trouble? Canadian Journal of Diagnosis 14: 31-32.

Melendez, L.J., and K.J.C. Finnie. 1997. Summer road blocks. Canadian Journal of Diagnosis 14: 29-30.

Melendez, L.J., and K.J.C. Finnie. 1998. Which one will get there first? Canadian Journal of Diagnosis 15: 57-58.

Borron, P.J., E.C. Crouch, J.F. Lewis, J.R. Wright, F. Possmayer, and L.J. Fraher. 1998. Recombinant rat surfactant associated protein D inhibits human T lymphocyte proliferation and IL-2 production. Journal of Immunology 161: 4315-4320.

Gagnon, R., J. Murotsuki, J.R.G. Challis, L.J. Fraher, and B.S. Richardson. 1997. Fetal sheep endocrine responses to sustained hypoxemic stress after chronic fetal placental embolization. American Journal of Physiology 272: E817-E823.

Hodsman, A.B., M. Kiesel, L.J. Fraher, P.H. Watson, and L.W. Stitt. 1998. Comparison of the response of pelvic and proximal tibial cancellous bone in rat to ovariectomy with estrogen replacement. Bone 23: 267-274.

Murotsuki, J., J.R.G. Challis, V.K.M. Han, L.J. Fraher, and R. Gagnon. 1997. Chronic fetal placental embolization and hypoxemia causes hypertension and myocardial hypertrophy in fetal sheep. American Journal of Physiology 272: R201-R207.

Stein, P., S.E. White, J. Homan, L.J. Fraher, H.H.G. McGarrigle, M.A. Hanson, and A.D. Bocking. 1998. Fetal endocrine responses to prolonged reduced uterine blood flow are altered following bilateral sectioning of the carotid sinus and vagus nerves. Journal of Endocrinology 157: 149-155.

Thornton, M., D. Holdsworth, D. Watson, L.J. Fraher, A.B. Hodsman, and D. Drost. 1997. Rapid small animal dexa using an area detector. Journal of Bone and Mineral Research 12 (S1): S261.

Watson, P.H., D. Drost, M. Thornton, D. Holdsworth, L.J. Fraher, A. Hodsman, J. Hock, and H. Bryant. 1997. Does the addition of raloxifene analogue (LY117018) allow for reduced PTH dosing during reversal fo osteopenia in the ovariedtomized rat? Journal of Bone and Mineral Research 12 (S1): S348.

Watson, P.H., M. Kiesel, D. DeSousa, L.J. Fraher, and A.B. Hodsman. 1997. Growth factor mRNA analysis by semi-quantitative RT-PCR trabecular bone of OVX rats treated with PTH +/- estrogen. Journal of Bone and Mineral Research 12 (S1): S336.

Watson, P., D. Drost, M. Thornton, D. Holdsworth, L.J. Fraher, A. Hodsman, J. Hock, and H. Bryant. 1997. Does raloxifene analogue (LY117018) maintain the gain in bone mass seen in osteopenic ovariectomized rats previously treated with an anabolic regimen of parathyroid hormone combined with raloxifene? Journal of Bone and Mineral Research 12 (S1): S347.

Badner, N.H., K. Drader, D.J. Freeman, and J.D. Spence. 1998. The Use of Intra-operative Nitrous Oxide Leads to Postooperative Increases in Plasma Homocysteine. Anesthesia and Analgesia 87: 711-713.

Ozcay, N., J. Fryer, D. Grant, D.J. Freeman, B. Garcia, and B. Zhong. 1997. Budesonide, A Locally Acting Steroid Prevents Graft Rejection in a Rat Model of Intestinal Transplantation. Transplantation 63: 1220-1225.

Ferguson, K.A., and C.F.P. George. 1998. A quick reference guide for clinicians. Sleep Medicine (Spring).

Vogel, S.D., C.D. Bayliff, and C.F.P. George. 1998. Zopiclone-associated respiratory depression. Canadian Journal of Hospital Pharmacy 51: 58-60.

Gerace, R.V. 1998. Drugs, Part A: Poisoning. Coma and Impaired Consciousness: A Clinical Perspective. G.B. Young, A.H. Ropper, and C.F. Bolton. New York: McGraw-Hall. 457-469.

Gerace, R.V., and W.A. McCauley. 1997. Emergency Medicine: Progress, Frustation and Controversy. Canadian Medical Association Journal 157: 1683-1684.

Gerace, R.V., W.A. McCauley, and E.F. Wijdicks. 1998. Emergency Management of the Comatose Patient. Coma and Impaired Consciousness: A Clinical Perspective. G.B. Young, A.H. Ropper, and C.F. Bolton. New York: McGraw-Hill. 563-578.

Ghent, C. 1998. Family Physicians on Care of Liver Transplant Patients. Copyrighted teaching program software.

Gilbert, K., P.P. Gleason, D.E. Singer, T.J. Marrie, C.M. Coley, D.S. Obrosky, J.R. Lave, W.N. Kapoor, and M.J. Fine. 1998. Variations in Antimicrobial Use and Cost in More than 2000 Patients with Community-Acquired Pneumonia. American Journal of Medicine 104: 17-27.

Larocque, B.J., K. Gilbert, and W.F. Brien. 1997. A Point Score System to Predict the Likelihood of Blood Transfusion Following Hip of Knee Arthroplasty. Transfusion 37: 463-467.

Larocque, B.J., K. Gilbert, and W.F. Brien. 1998. Prospective Validation of a Point Score System for Predicting Blood Transfusion Following Hip and Knee Replacement. Transfusion 38: 932-937.

Gilkinson, T. 1998. Hypothermia. Canadian Journal of CME (January).

Gilmour, J.G. 1997. HIV Post-Exposure Prophylaxis. Patient Care Journal 8: 28-30.

Atkinson, K., S. Tokmakajian, W.C. Watson, and J.C. Gregor. 1997. An evaluation of the endomysial antibody for celiac disease: Operating properties and associated cost implications in clinical practice. Canadian Journal of Gastroenterology 11 (8): 673-677.

Gregor, J.C., J.W.D. McDonald, N. Klar, R. Wall, K. Atkinson, B. Lamba, and B.G. Feagan. 1997. An evaluation of utility measurements in Crohn's disease. Inflammatory Bowel Disease 3 (4): 265-276.

Stal, J., J.C. Gregor, H.G. Preiksaitis, and R.P.E. Reynolds. 1998. A cost-utility analysis comparing omeprazole with ranitidine in the maintenance therapy of peptic esophageal stricture. Canadian Journal of Gastroenterology 12: 43-49.

Feldman, R.D., and R. Gros. 1998. Impaired vasodilator function in hypertension: The role of alterations in receptor/G-protein coupling. Trends in Cardiovascular Medicine 8: 297-305.

Guenther, L. 1997. Drugs in Pregnancy--Which ones to use. Dermatology Nursing 9 (4): 233-238.

Guenther, L. 1998. Fixed cutaneous sporotrichosis. Dermatology Casebook 4 (2): 1-4.

Guenther, L. 1997. Government Sponsored Drug Plans--Comprehensive versus limited coverage Point/Counterpoint. Journal of Cutaneous Medicine and Surgery 2 (1): 27-29.

Guenther, L. 1998. Sunburn (Chapter 57). Therapeutic Choices. 2nd ed. Ottawa, Ontario: Canadian Pharmaceutical Association. 437-442.

Rosenthal, D., L. Guenther, and J. Kelly. 1997. Some current thoughts on the use of methotrexate in patients with psoriasis. Journal of Cutaneous Medicine and Surgery 2 (1): 41-46.

McFarlane, M., M. Harth, and W.J. Wall. 1997. Liver transplant in adult Still's disease. Journal of Rheumatology 24: 2038-2041.

Nielson, W.R., M. Harth, and D.A. Bell. 1997. Out-Patient cognitive-behavioural treatment of fibromyalgia: Impact on pain response and health status. Pain Research Management 2: 145-150.

Riestra Noriega, J.L., and M. Harth. 1997. Pharmacology of Gold Compounds in Rheumatoid Arthritis: A review. Canadian Journal of Clinical Pharmacology 4: 127-136.

Boright, A.P., P.W. Connelly, J.H. Brunt, K. Morgan, and R.A. Hegele. 1998. Association and linkage of LDLR gene variation with variation in plasma low density lipoprotein cholesterol. Journal of Human Genetics 43: 153-159.

Boright, A.P., P.W. Connelly, J.H. Brunt, S.W. Scherer, L.C. Tsui, and R.A. Hegele. 1998. Genetic Variation in paraoxonase-1 and paraoxonase-2 is associated with variation in plasma lipoproteins in Alberta Hutterites. Atherosclerosis 139: 131-136.

Hegele, R.A. 1997. Small genetic effects in complex diseases: areview of regulatory sequence variants in dyslipoproteinemia and atherosclerosis. Clinical Biochemistry 30: 183-188.

Hegele, R.A., W.C. Breckenridge, J.H. Brunt, and P.W. Connelly. 1997. Genetic variation in factor VII associated with variation in plasma lipoprotein(a) concentration. Arteriosclerosis, Thrombosis, and Vascular Biology 17: 1701-1706.

Hegele, R.A., W.C. Breckenridge, D.W. Cox, G.F. Maguire, J.A. Little, and P.W. Connelly. 1998. Elevated low density lipoprotein triglyceride concentrations in subjects heterozygous for hepatic lipase S267F variant. Arteriosclerosis, Thrombosis, and Vascular Biology 18: 1212-1216.

Hegele, R.A., H. Cao, S.B. Harris, A.J.G. Hanley, and B. Zinman. 1998. Hemochromatosis gene mutation and diabetes mellitus in aboriginal Canadians. Annals of Internal Medicine 129: 587.

Hegele, R.A., P.W. Connelly, A.J.G. Hanley, F. Sun, S.B. Harris, and B. Zinman. 1997. Common genomic variation in the APOC3 gene promoter associated with variation in plasma triglycerides. Arteriosclerosis, Thrombosis, and Vascular Biology 17: 2753-2758.

Hegele, R.A., PW. Connelly, S.W. Scherer, A.J.G. Hanley, S.B. Harris, L.-C. Tsui, and B. Zinman. 1997. Paraoxonase-2 gene (PON2) G148 variant associated with elevated fasting blood glucose in NIDDM. Journal of Clinical Endocrinology and Metabolism 82: 3373-3377.

Hegele, R.A., S.B. Harris, H. Cao, A.J. Hanley, and B. Zinman. 1998. Factor V Leiden (F5 Q506) and vascular disease in Canadian Oji-Cree. Diabetes Care 21: 1203.

Hegele, R.A., S.B. Harris, A.J.G. Hanley, H. Azouz, P.W. Connelly, and B. Zinman. 1998. Absence of association between variation of the bate-3-adrenergic receptor and metabolic phenotypes in Oji-Cree. Diabetes Care 21: 851-854.

Hegele, R.A., S.B. Harris, A.J.G. Hanley, F. Sun, P.W. Connelly, and B. Zinman. 1998. -6A promoter variant of angiotensinogen and blood pressure variation in Canadian Oji-Cree. Journal of Humans Genetics 43: 37-41.

Hegele, R.A., T.M.S. Wolever, A.J.G. Hanley, S.B. Harris, and B. Zinman. 1998. Methylenetetra-hydrofolate reductase gene, dietary folate, NIDDM and atherosclerosis in Canadian Oji-Cree. Diabetes Care 21: 322-323.

Hegele, R.A., T.M.S. Wolever, J.A. Story, P.W. Connelly, and D.J.A. Jenkins. 1997. Intestinal fatty acid binding protein variation associated with variation in response of plasma lipoproteins to dietary fibre. European Journal of Clinical Investigation 27: 857-862.

Kang, A.K., D.J.A. Jenkins, T.M.S. Wolever, M.W. Huff, G.F. Maguire, P.W. Connelly, and R.A. Hegele. 1997. Apolipoprotein E R112; R251G: A carboxy-terminal variant associated with hyperlipidemia and coronary heart disease. Mutation Research Genomics 382: 57-65.

Mendelcorn, R., P.W. Connelly, A. Boright, T.K. Young, and R.A. Hegele. 1998. F5 Q506 mutation and the low prevalence of cardiovascular disease in Canadian Inuit. Journal of Investigative Medicine 46: 232-235.

Arany, E., and D.J. Hill. 1998. Fibroblast growth factor-2 and fibroblast growth factor receptor-1 mRNA expression and peptide localization in placentae from normal and diabetic pregnancies. Placenta 19: 133-142.

Hill, D.J., J. Petrik, and E. Arany. 1998. Growth factors and the regulation of fetal growth. Diabetes Care 21 (Suppl 2): B60-B69.

Hill, D.J., J. Petrik, E. Arany, W. Reik, and J.M. Pell. 1998. Insulin-like growth factors in the development of the pancreas. Molecular Mechanisms to regulate the activities of Insulin-like Growth Factors. K. Takano, N. Hizuka, and S. Takahashi. Amsterdam: Elsevier Science. 145-153.

Petrik, J., E. Arany, T.J. McDonald, and D.J. Hill. 1998. Apoptosis in the pancreatic islet cells of the neonatal rat is associated with a reduced expression of insulin-like growth factor-II which may act as a survival factor. Endocrinology 139: 2994-3004.

Tucci, M., K. Nygard, B.V. Tanswell, W. Farber, D.J. Hill, and V.K.M. Han. 1998. Modulation of insulin-like growth factor (IGF) and IGF binding protein (IGFBP) biosynthesis by hypoxia in cultured vascular endothelial cells. Journal of Endocrinology 157: 13-24.

Wang, J.F., V. Milosveski, C. Schramek, G.H. Fong, G.P. Becks, and D.J. Hill. 1998. Presence and possibel role of vascular endothelial growth factor (VEGF) in thyroid cell growth and function. Journal of Endocrinology 157: 5-12.

Xiao, Q., X. Han, E. Arany, D.J. Hill, J.R.G. Challis, and T.J. McDonald. 1998. Human placenta and fetal membranes contain peptide YY1-36 and peptide YY3-36. Journal of Endocrinology 156: 485-492.

Hodsman, A.B. 1998. Bone mineral density T scores: assessing the risk. Clinical and Investigative Medicine 21: 94-96.

Hodsman, A.B., M. Kiesel, L.J. Fraher, P.H. Watson, and L.W. Stitt. 1998. Comparison of the response of pelvic and proximal tibial cancellous bone in rat to ovariectomy with estrogen replacement. Bone 23: 267-274.

Thornton, M., D. Holdsworth, D. Watson, L.J. Fraher, A.B. Hodsman, and D. Drost. 1997. Rapid small animal dexa using an area detector. Journal of Bone and Mineral Research 12 (S1): S261.

Watson, P.H., D. Drost, M. Thornton, D. Holdsworth, L.J. Fraher, A. B. Hodsman, J. Hock, and H. Bryant. 1997. Does the addition of raloxifene analogue (LY117018) allow for reduced PTH dosing during reversal fo osteopenia in the ovariedtomized rat? Journal of Bone and Mineral Research 12 (S1): S348.

Watson, P., D. Drost, M. Thornton, D. Holdsworth, L.J. Fraher, A. B. Hodsman, J. Hock, and H. Bryant. 1997. Does raloxifene analogue (LY117018) maintain the gain in bone mass seen in osteopenic ovariectomized rats previously treated with an anabolic regimen of parathyroid hormone combined with raloxifene? Journal of Bone and Mineral Research 12 (S1): S347.

Watson, P.H., M. Kiesel, D. DeSousa, L.J. Fraher, and A.B. Hodsman. 1997. Growth factor mRNA analysis by semi-quantitative RT-PCR trabecular bone of OVX rats treated with PTH +/- estrogen. Journal of Bone and Mineral Research 12 (S1): S336.

Hollomby, D.J. 1998. Manpower issues outside the US Canada looks at its supply of nephrologists. Nephrology News Issues 12: 15-17.

Delva, D., L. Facey-Crowther, J.M. Howard, M. Marks, and D. Richardson-Gerek. 1998. The future of EFPO. EFPO News (February): 3.

Yoemans, N.D., Z. Tulassay, L. Juhasz, I. Racz, and J.M. Howard. 1998. A comparison of omeprazole with ranitidine for ulcers associated with nonsteroidal anti-inflammatory drugs. New England Journal of Medicine 338: 719-726.

Howson, W., K. Howson-Jan, A.M. Smith, J. Lipton, and J. Wade. 1997. Polymorphisms of CD31 and frequency of acute graft-versus-host disease. Blood 90: 388b.

Guan, J., M.T. Behme, P. Zucker, P. Atkison, I. Hramiak, R. Zhong, and J. Dupre. 1998. Glucose turnover and insulin sensitivity in rats with pancreatic islet transplants. Diabetes 47: 1020-1026.

Burnett, J.R., L.J. Wilcox, D.E. Telford, S.J. Kleinstiver, Barrett. P.H.R., and M.W. Huff. 1998. Inhibition of cholesterol esterification by DuP 128 decreases hepatic apo B secretion in. Biochimica et Biophysica Acta 1393: 63-79.

Burnett, J.R., L.J. Wilcox, D.E. Telford, S.J. Kleinstiver, P.H.R. Barrett, R.S. Newton, and M.W. Huff. 1997. Atorvastatin decreases both VLDL and LDL apolipoprotein B production in miniature pigs. Arteriosclerosis, Thrombosis and Vascular Biology 17: 2589-2600.

Kang, A.K., D.J.A. Jenkins, T.M.S. Wolever, M.W. Huff, G.F. Maguire, P.W. Connelly, and R.A. Hegele. 1997. Apolipoprotein E R112; R251G: A carboxy-terminal variant associated with hyperlipidemia and coronary heart disease. Mutation Research Genomics 382: 57-65.

Whitman, S.C., D.B. Miller, B.M. Wolfe, and M.W. Huff. 1998. Oxidized type IV hypertriglyceridemic VLDL-remnants are more atherogenic than oxidized LDL. Journal of Lipid Research 39: 1008-1020.

The GUSTO III Investigators, and G. Jablonsky. 1997. A comparison of reteplase with alteplase for acute myocardial infarction. New England Journal of Medicine 337: 118-1123.

Atkinson, P.R., G.I. Joubert, C. Guiradon, R. Armstrong, W. Wall, S. Asfar, and D. Grant. 1997. Arteritis and increased intracellular calcium as a possible mechanism for tacrolimus related cardiac toxicity in a paediatric transplant recipient. Transplantation 64 (5): 773-775.

Joubert, G.I. 1998. Dehydration in Children - Fluid and Electrolyte Disorders Section. Therapeutic Choices. Canadian Pharmaceutical Association.

Joubert, G.I. 1997. Hemodynamic Management. Manual of Pediatric Critical Care. N.C. Singh. W.B. Saunders Company.

Zufelt, K.W., H.C. Rosenberg, M.D. Li, and G.I. Joubert. 1998. The Electrocardiogram (ECG) and the Secundum Atrial Septal Defect (ASD): A Re-examination in the Era of Echocardiography. Canadian Journal of Cardiology 14 (2): 227-232.

Chen, L.M., C.M. Martin, S.P. Keenan, and W.J. Sibbald. 1998. Patients readmitted to the Intensive Care Unit during the same hospitalization: Clinical features and outcomes. Critical Care Medicine 26: 1834-1841.

Keenan, S.P., and D. Brake. 1998. An evidence based approach to non-invasive ventilation in acute respiratory failure. Critical Care Clinics 14: 359-373.

Keenan, S.P., K.D. Busche, L.M. Chen, R. Esmail, W.J. Sibbald, and K.J. Inman. 1998. The withdrawal and withholding of life support in the Intensive Care Unit: A comparison between teaching and community hospitals. Critical Care Medicine 26: 245-261.

Keenan, S.P., K.A. Ferguson, M. Chan-Yeung, and J.A. Fleetham. 1998. Prevalence of sleep disorder breathing in a population of Canadian grainworkers. Canadian Respiratory Journal 5: 184-190.

Keenan, S.P., P.D. Kernerman, D.J. Cook, C.M. Martin, D.G. McCormack, and W.J. Sibbald. 1997. Effect of noninvasive positive pressure ventilation on mortality in patients admitted with acute respiratory failure: A meta-analysis. Critical Care Medicine 25: 1685-1692.

Keenan, S.P., D. Massel, K.J. Inman, and W.J. Sibbald. 1998. A systematic review of the cost-effectiveness of noncardiac transitional care units. Chest 113: 172-177.

Kirby, A.S., and S.P. Keenan. 1998. High Risk Surgery. Bone's Atlas of Pulmonary and Critical Care Medicine. Philadelphia: Current Medicine, Inc.

Kojlak, J., S.P. Keenan, D. Plotkin, N. Fish, and R. Esmail. 1998. Are the bereavement needs of families and healthcare workers currently being Met? CACCN 1: 12-16.

Pang, D., S.P. Keenan, D.J. Cook, and W.J. Sibbald. 1998. The effect of positive airway support on mortality and the need for intubation in cardiogenic pulmonary edema: A systematic review. Chest 114: 1185-1182.

Sibbald, W.J., and S.P. Keenan. 1997. Show me the evidence: A critical appraisal of the pulmonary artery consensus conference and other musings on how critical care practitioners need to improve the way we conduct business. Critical Care Medicine 25: 2060-2063.

Sampath-Kumar, R., M. Yu, M.W. Khalil, and K.P. Yang. 1997. Metyrapone is a competitive inhibitor of 11B-hydroxysteroid dehydrogenase type 1 reductase. Journal of Steroid Biochemistry and Molecular Biology 62: 195-199.

Cook, D., G. Guyatt, J. Marshall, D.J. Leasa, H. Fuller, R. Hall, S. Peters, F.S. Rutledge, L. Griffith, A. McLellan, G. Wood, and A.S. Kirby. 1998. A comparison of sucralfate and ranitidine for the prevention of upper gastrointestinal bleeding in patients requiring mechanical ventilation. New England Journal of Medicine 338 (12): 791-797.

Kirby, A.S., and S.P. Keenan. 1998. High Risk Surgery. Bone's Atlas of Pulmonary and Critical Care Medicine. Philadelphia: Current Medicine, Inc.

Basta, M.N., A.D. Krahn, G.J. Klein, M. Rosenbaum, and C. Le Feuvre. 1997. Safety of slow pathway ablation in patients with atrioventricular node reentrant tachycardia and a long fast pathway effective refractory period. American Journal of Cardiology 80: 155-159.

Basta, M., G.J. Klein, R. Yee, A.D. Krahn, and J. Lee. 1997. Current role of pharmacologic therapy for patients with paroxysmal supraventicular tachycardia. Cardiology Clinics 15 (4): 587-597.

Guiraudon, G.M., C.M.J. Guiraudon, and G.J. Klein. 1997. Surgical approaches. Arrhythmogenic right ventricular cardiomyopathy/dysplasia. Exerpta Medica International Congress Series 1122. A. Nava, L. Rossi, and G. Thiene. New York: Elsevier. 392-338.

Guiraudon, G.M., C.M. Guiraudon, G.J. Klein, and R. Yee. 1998. Atrial fibrillation: Functional anatomy and surgical rationales. Ten years of radiofrequency catheter ablation. C. Moro, and J. Farre. Armonk, NY: Futura Publishing Co. 289-310.

Guiraudon, G.M., C.M. Guiraudon, G.J. Klein, R. Yee, and A.D. Krahn. 1998. Surgical anatomy of the atrio-ventricular junction. Ten Years of Radiofrequency Catheter Ablation. C. Moro, and J. Farre. Armonk, NY: Futura Publishing Co., Inc. 59-73.

Guiraudon, G.M., G.J. Klein, C.M. Guiraudon, and R. Yee. 1998. Surgical approaches to supraventricular tachycardia. Nonpharmacological Therapy of Arrhythmias for the 21st Century: The State of the Art. I. Singer, S.S. Barold, and A.J. Camm. Armonk, NY: Futura Publishing. 631-652.

Guiraudon, G.M., G.J. Klein, C.M. Guiraudon, and R. Yee. 1998. Surgical treatment of atrial fibrillation: What's new? Atrial Flutter and Fibrillation: From Basic to Clinical Applications. N. Saoudi, W. Schoels, and N. El-Sherif. Armonk, NY: Futura Publishing Company, Inc. 349-360.

Guiraudon, G.M., G.J. Klein, R. Yee, and D. Switzer. 1998. Surgical treatment of ventricular tachycardias. Nonpharmacological Therapy of Arrhythmias for the 21st Century: The State of the Art. I. Singer, S.S. Barold, and A.J. Camm. Armonk, NY: Futura Publishing Co, Inc. 667-683.

Kerr, C.R., J. Boone, S.J. Connolly, P. Dorian, M. Green, G.J. Klein, D. Newman, R. Sheldon, M. Talajic, and The Canadian Registry of Atrial Fibrillation. 1998. A non-interventional follow-up of patients after the first diagnosis of AF. American Journal of Cardiology 82: 82N-85N.

Klein, G.J. 1997. Atrial fibrillation: What treatment should we use? ACC Current Journal Review 6: 46-47.

Klein, G.J. 1997. The ten most commonly asked questions about Wolff-Parkinson-White syndrome. Cardiology in Review 5: 230-232.

Krahn, A.D., G.J. Klein, and R. Yee. 1998. The approach to the athlete with Wolff Parkinson White Syndrome: Risk of sudden cardiac death. Sudden Cardiac Death in the Athlete. N.A.M. Estes, D.N. Salem, and P.J. Wang. Armonk, NY: Futura Publishing Co., Inc. 237-252.

Krahn, A.D., G.J. Klein, and R. Yee. 1997. Hysteresis of the RT interval with exercise: A new marker for the long QT syndrome. Circulation 96: 1551-1556.

Krahn, A.D., G.J. Klein, and R. Yee. 1997. Perfecting your clinical approach to syncope. Perspectives in Cardiology 13: 27-42.

Krahn, A.D., G.J. Klein, and R. Yee. 1998. Pushing the ablation frontier in atrioventricular node reentrant tachycardia. European Heart Journal 19: 828-829.

Krahn, A.D., G.J. Klein, and R. Yee. 1997. Recurrent Syncope: Experience with an Implantable Loop Recorder. Cardiology Clinics: Syncope 15 (2): 13-26.

Krahn, A.D., G.J. Klein, and R. Yee. 1998. Recurrent unexplained syncope in a 69 year old man. Cardiac Electrophysiology Monthly 1: 35-37.

Krahn, A.D., G.J. Klein, and R. Yee. 1997. Recurrent unexplained syncope: When all else fails. Syncope: Mechanisms and management. B.P. Grubb, and B. Olansky. Armonk, NY: Futura Publishing Co. 359-369.

Krahn, A.D., G.J. Klein, R. Yee, M.N. Basta, and J.K. Lee. 1997. Progressive anterior ablation in the coronary sinus region: Evidence to support the presence of a slow pathway in normal patients. Circulation 96: 3477-3483.

Krahn, A.D., G.J. Klein, R. Yee, and C. Norris. 1998. Final results from a pilot study with an implantable loop recorder to determine the etiology of syncope in patients with negative noninvasive and invasive testing. American Journal of Cardiology 82: 117-119.

Lee, J.K., R. Yee, G.J. Klein, A.D. Krahn, and M.N. Basta. 1997. Electrophysiology studies in the assessment and management of patients involved in high risk occupations and activities. Cardiac EP Reviews 4: 473-477.

Li, H., R. Yee, R.K. Thakur, and G.J. Klein. 1997. The effect of variable retrograde penetration on dual AV nodal pathways: Observations before and after slow pathway ablation LDD. PACE 20: 2146-2153.

Qi, A., C.R. Kerr, J.A. Wong Xyeung-Lai-Wah, S. Connolly, G.J. Klein, M. Green, M. Talajic, R. Sheldon, and J. Boone. 1997. Who wants to be treated for atrial fibrillation?: Relationship of Clinical variables to symptoms. Nonpharmacological Management of Atrial Fibrillation. A.J. Camm, and F.D. Murgatroyd. Armonk, NY: Futura Publishing Co. 15-22.

Simpson, C.S., M.A. Fisher, M.J. Curtis, A.D. Krahn, H. Abdollah, S.R. Raj, F.J. Brennan, G.J. Klein, and R. Yee. 1998. Correlation of waiting time with adverse events in patients admitted for nonelective permanent pacemaker implantation. Canadian Journal of Cardiology 14 (6): 817-821.

Bach, D.S., J.L. Cohen, P.M. Fioretti, L.E. Ginzton, J. Sklar, M. Zabalgoitia, L. Crouse, The International Arbutamine Study Group, and W.J. Kostuk. 1998. Safety and efficacy of closed-loop arbutamine stress echocardiography for detection of coronary artery disease. American Journal of Cardiology 81: 32-35.

Carrier, M., M. Rivard, D. Latter, W.J. Kostuk, and The CASCADE Investigators. 1998. Predictors of early mortality after heart transplantation: The Canadian transplant experience from 1981 to 1992. Canadian Journal of Cardiology 14: 703-707.

Thibeault, C., and W.J. Kostuk. 1998. Recommendations on air travel for heart patients. Perspectives in Cardiology 14: 27-56.

Berenson, J.R., A. Lichteastein, L. Porter, M.A. Dimopoulous, R. Bordoni, S. George, A. Lipton, A. Keller, O. Ballester, M.J. Kovacs, et al, and The Myeloma Aredia Study Group. 1998. Long-term pamidronate treatment of advanced multiple myeloma patients reduces skeletal events. Journal of Clinical Oncology 16: 593-602.

Gill, J., and M.J. Kovacs. 1997. Successful use of orgaran for the treatment of heparin induced thrombocytompenia (HIT) during twin pregnancy. Obstetrics & Gynecology 90: 648-650.

Gupta, A.K., M.J. Kovacs, and D.N. Sauder. 1998. Heparin induced thrombocytopenia: An adverse effect of heparin therapy with potentially serious consequences. Annals of Pharmacotherapy 32: 55-59.

Kovacs, M.J. 1998. Alternate anticoagulants for patients with heparin-induced thrombocytopenia. Consultant 38: 1420.

Kovacs, M.J., M. Keeney, K. MacKinnon, and K. Weir. 1997. Rabbit brain derived thromboplastins do not give equivalent INR's for patients with liver disease. Laboratory Hematology 3: 279-281.

Kovacs, M.J., K. Weir, K. MacKinnon, M. Keeney, W.F. Brien, and M.K. Cruickshank. 1998. Body weight does not predict for anti-Xa levels after fixed dose prophylaxis with Enoxaparin after orthopedic surgery. Thrombosis Research 91: 137-142.

The Columbus Investigators, M.J. Kovacs, et al. 1997. Low molecular weight heparin in the treatment of patients with venous thromboembolism. New England Journal of Medicine 337 (10): 657-662.

Basta, M.N., A.D. Krahn, G.J. Klein, M. Rosenbaum, and C. Le Feuvre. 1997. Safety of slow pathway ablation in patients with atrioventricular node reentrant tachycardia and a long fast pathway effective refractory period. American Journal of Cardiology 80: 155-159.

Basta, M., G.J. Klein, R. Yee, A.D. Krahn, and J. Lee. 1997. Current role of pharmacologic therapy for patients with paroxysmal supraventicular tachycardia. Cardiology Clinics 15 (4): 587-597.

Guiraudon, G.M., C.M. Guiraudon, G.J. Klein, R. Yee, and A.D. Krahn. 1998. Surgical anatomy of the atrio-ventricular junction. Ten Years of Radiofrequency Catheter Ablation. C. Moro, and J. Farre. Armonk, NY: Futura Publishing Co., Inc. 59-73.

Krahn, A.D. 1997. Piecing together the causes of syncope. Canadian Journal of Continuing Medical Education 9: 48-62.

Krahn, A.D., G.J. Klein, and R. Yee. 1998. The approach to the athlete with Wolff Parkinson White Syndrome: Risk of sudden cardiac death. Sudden Cardiac Death in the Athlete. N.A.M. Estes, D.N. Salem, and P.J. Wang. Armonk, NY: Futura Publishing Co., Inc. 237-252.

Krahn, A.D., G.J. Klein, and R. Yee. 1997. Hysteresis of the RT interval with exercise: A new marker for the long QT syndrome. Circulation 96: 1551-1556.

Krahn, A.D., G.J. Klein, and R. Yee. 1997. Perfecting your clinical approach to syncope. Perspectives in Cardiology 13: 27-42.

Krahn, A.D., G.J. Klein, and R. Yee. 1998. Pushing the ablation frontier in atrioventricular node reentrant tachycardia. European Heart Journal 19: 828-829.

Krahn, A.D., G.J. Klein, and R. Yee. 1997. Recurrent Syncope: Experience with an Implantable Loop Recorder. Cardiology Clinics: Syncope 15 (2): 13-26.

Krahn, A.D., G.J. Klein, and R. Yee. 1998. Recurrent unexplained syncope in a 69 year old man. Cardiac Electrophysiology Monthly 1: 35-37.

Krahn, A.D., G.J. Klein, and R. Yee. 1997. Recurrent unexplained syncope: When all else fails. Syncope: Mechanisms and management. B.P. Grubb, and B. Olansky. Armonk, NY: Futura Publishing Co. 359-369.

Krahn, A.D., G.J. Klein, R. Yee, M.N. Basta, and J.K. Lee. 1997. Progressive anterior ablation in the coronary sinus region: Evidence to support the presence of a slow pathway in normal patients. Circulation 96: 3477-3483.

Krahn, A.D., G.J. Klein, R. Yee, and C. Norris. 1998. Final results from a pilot study with an implantable loop recorder to determine the etiology of syncope in patients with negative noninvasive and invasive testing. American Journal of Cardiology 82: 117-119.

Lee, J.K., R. Yee, G.J. Klein, A.D. Krahn, and M.N. Basta. 1997. Electrophysiology studies in the assessment and management of patients involved in high risk occupations and activities. Cardiac EP Reviews 4: 473-477.

Simpson, C.S., M.A. Fisher, M.J. Curtis, A.D. Krahn, H. Abdollah, S.R. Raj, F.J. Brennan, G.J. Klein, and R. Yee. 1998. Correlation of waiting time with adverse events in patients admitted for nonelective permanent pacemaker implantation. Canadian Journal of Cardiology 14 (6): 817-821.

Bailey, D.G., J.H. Kreeft, C. Munoz, J.D. Freeman, and J.R. Bend. 1998. Grapefruit juice-felodipine interaction: effect of naringin and 6', 7'-dihydroxybergamottin in humans. Clinical Pharmacology & Therapeutics 64: 248-256.

Larocque, B.J., K. Gilbert, and W.F. Brien. 1997. A Point Score System to Predict the Likelihood of Blood Transfusion Following Hip of Knee Arthroplasty. Transfusion 37: 463-467.

Larocque, B.J., K. Gilbert, and W.F. Brien. 1998. Prospective Validation of a Point Score System for Predicting Blood Transfusion Following Hip and Knee Replacement. Transfusion 38: 932-937.

Preiksaitis, H.G., and L.G. Laurier. 1998. Pharmacological and molecular characterization of muscarinic receptors in cat espophageal smooth muscle. Journal of Pharmacology and Experimental Therapeutics 285: 853-861.

Auersvald, L.A., D.M. Rothstein, S.C. Oliveira, C.Q. Khuong, H. Ondera, A.I. Lazarovits, and G.P. Basadonna. 1997. Indefinite islet allograft survival in mice after a short course of treatment with anti-CD45 monoclonal antibodies. Transplantation 63: 1355-1369.

Bassadona, G.P., L. Auersvald, C.Q. Khuong, X.X. Zheng, N. Kashio, D. Zekzer, M. Minozza, H.-Y. Qian, L. Visser, A. Diepstra, A.I. Lazarovits, S. Poppema, T.B. Strom, and D.M. Rothstein. 1998. Antibody mediated targeting of CD45 isoforms: A novel immunotherapeutic strategy. Proceedings of the National Academy of Sciences USA 95: 3821-3826.

Dales, R., D. Miller, J. White, C. Dulberg, and A.I. Lazarovits. 1998. Influence of residential fungal contamination on peripheral blood lymphocyte populations in children. Archives of Environmental Health 53: 190-195.

Dolcetti, R., R. Giardini, C. Doglioni, R. Cariati, F. Pomponi, C. D'Orazi, S. Rao, A.I. Lazarovits, E.C. Butcher, and M. Boiocchi. 1997. a4B7 integrin expression is associated with the leukemic evolution of human and murine T cell lymphoblastic lymphomas. American Journal of Pathology 150: 1595-1605.

Drillenburg, P., R. van der Voort, G. Koopman, B. Dragosics, J.H.J.M. van Krieken, P. Kluin, J. Meenan, A.I. Lazarovits, T. Radaszkiewicz, and S.T. Pals. 1997. Preferential expression of the mucosal homing receptor integrin a4b7 in gastrointestinal non-hodgkin's lymphomas. American Journal of Pathology 150: 919-927.

Elewaut, D., F. DeKeyser, C. Cuvelier, A.I. Lazarovits, H. Mielants, G. Verbruggen, S. Sas, M. Devos, and E.M. Veys. 1998. Distinctive activated cellular subsets in colon from patients with Crohn's disease and ulcerative colitis. Scandinavian Journal of Gastroenterology 7: 743-748.

Kantele, A., J.M. Kantele, E. Savilahti, M. Westerholm, H. Arvilommi, A.I. Lazarovits, E.C. Butcher, and P.H. Makela. 1997. Homing potentials of circulating lymphocytes in humans depend on the site of activation. Journal of Immunology 158: 574-579.

Kohno, Y., N. Shimojo, M. Aoyagi, Y. Sannomiya, T. Nishimuta, H. Kojima, T. Katsuki, M. Tomiita, A.I. Lazarovits, D. Ringler, and Niimi. 1998. Increased expression of a4B7 integrin on food allergen-stimulated CD4+ T cells in active food allergic enterocolitis. Allergology International 47: 99-102.

Madrenas, J., and A.I. Lazarovits. 1998. Differential signaling through the T cell receptor: From biochemistry to transplantation tolerance. Histology and Histopathology 13: 221-229.

Tidswell, M., R. Pachynski, S.W. Wu, S.Q. Qiu, E. Dunham, N. Cochran, M.J. Briskin , P.J. Kilshaw, A.I. Lazarovits, D.P. Andrew, E.C. Butcher, T.A. Yednock, and D.J. Erle. 1997. Structure-function analysis of the integrin B7 subunit: Identification of domains involved in adhesion to MAdCAM-1. Journal of Immunology 159: 1497-1505.

Zhong, R.Z., and A.I. Lazarovits. 1998. Monoclonal antibody against CD45RB for the therapy of rejection and autoimmune disease. Journal of Molecular Medicine 76: 572-580.

Cook, D.J., S.D. Walter, R.J. Cook, L.E. Griffith, G.H. Guyatt, D.J. Leasa, R.Z. Jaeschke, and C. Brun-Buisson. 1998. Incidence of and risk factors for ventilator-associated pneumonia in critically ill patients. Annals of Internal Medicine 129: 433-440.

Cook, D., G. Guyatt, J. Marshall, D.J. Leasa, H. Fuller, R. Hall, S. Peters, F.S. Rutledge, L. Griffith, A. McLellan, G. Wood, and A.S. Kirby. 1998. A comparison of sucralfate and ranitidine for the prevention of upper gastrointestinal bleeding in patients requiring mechanical ventilation. New England Journal of Medicine 338 (12): 791-797.

Rutledge, F.S., and D.J. Leasa. 1998. Acute respiratory failure. Bone's Atlas of Pulmonary and Critical Care Medicine. R.C. Bone, G.D. Campbell, D. Payne, A.C. Arroliga, R.B. George, L.J. Goodman, and W.J. Sibbald. Philadelphia: Williams & Wilkins. 24.01-24.11.

Borron, P.J., E.C. Crouch, J.F. Lewis, J.R. Wright, F. Possmayer, and L.J. Fraher. 1998. Recombinant rat surfactant associated protein D inhibits human T lymphocyte proliferation and IL-2 production. Journal of Immunology 161: 4315-4320.

Ito, Y., S.E.E. Manwell, C.L. Kerr, R.A.W. Veldhuizen, L.-J. Yao, D. Bjarneson, L.A. McCaig, A.J. Barlett, and J.F. Lewis. 1998. Effects of ventilation strategies on the efficacy of exogenous surfactant therapy in a rabbit model of acute lung injury. American Journal of Respiratory and Critical Care Medicine 157: 149-155.

Ito, Y., R.A.W. Veldhuizen, L. Yao, L. McCaig, A. Bartlett, and J.F. Lewis. 1997. Ventilation strateies affect surfactant aggregate conversion in acute lung injury. American Journal of Respiratory and Critical Care Medicine 155: 493-499.

Kerr, C.L., Y. Ito, S.E.E. Manwell, R.A.W. Veldhuizen, L.-J. Yao, L.A. McCaig, and J.F. Lewis. 1998. Effects of surfactant distribution and ventilation strategies on efficacy of exogenous surfactant. Journal of Applied Physiology 85: 676-685.

Lewis, J.F. 1997. Canadian asthma guidelines revisited. Patient Care Canada 8: 28.

Lewis, J.F. 1997. Revisiting the Canadian asthma guidelines. Canadian Journal of Continuing Medical Education (Aug): 31-43.

Lewis, J.F., J.S. Dhillon, R.N. Singh, C.C. Johnson, and T.C. Frewen. 1997. Exogenous surfactant therapy for pediatric therapy for pediatric patients with the acute respiratory distress syndrome. Canadian Respiratory Journal 4: 21-26.

Lewis, J.F., and T. Nolan. 1998. How do I manage my acutely severe asthmatic? Canadian Journal of Diagnosis (Apr): 137-144.

Malloy, J., L. McCaig, R.A.W. Veldhuizen, L. Yao, J. Whitsett, M. Joseph, and J.F. Lewis. 1997. Alterations of the endogenous surfactant system in septic adult rats. American Journal of Respiratory and Critical Care Medicine 156: 617-623.

Novick, R.J., A.A. Gilpin, K.E. Gehman, I.S. Ali, R.A.W. Veldhuizen, J. Duplan, L. Denning, F. Possmayer, D. Bjarneson, and J.F. Lewis. 1997. Mitigation of injury in canine lung grafts by exogenous surfactant. Journal of Thoracic and Cardiovascular Surgery 113: 342-353.

Possmayer, F., R.J. Novick, R.A.W. Veldhuizen, J. Lee, D. Bjarneson, and J.F. Lewis. 1998. Potential role for pulmonary surfactant in lung transplantation. Acute Respiratory Distress Syndrome: Cellular and Molecular Mechanisms and Clinical Management. S. Matalon, and J.I. Szajder. New York: Plenum Press. 117-124.

Vanderzwan, J., R.A.W. Veldhuizen, and J.F. Lewis. 1998. A current and future perspective of exogenous surfactant therapy for acute respiratory distress syndrome. Current Opinions in Critical Care Medicine 4: 21-27.

Veldhuizen, R.A.W., Y. Ito, J. Marcou, L.-J. Yao, L. McCaig, and J.F. Lewis. 1997. Effects of lung injury on pulmonary surfactant aggregate conversion in vivo and in vitro. American Journal of Physiology 272: L872-L878.

Bolton, F., H. Remtulla, L. Bernardi, R.M. Lindsay, O. Maryniak, and S.R. Burton. 1997. Distinctive electrophysiology features of denervated muscle in uremic patients. Journal of Clinical Neurophysiology 14 (6): 539-542.

Lindsay, R.M. 1997. Assessment of access recirculation during haemodialysis. Current Opinion in Nephrology and Hypertension 6: 570-574.

Lindsay, R.M., P.G. Blake, P. Malek, G. Posen, B. Martin, and E. Bradfield. 1998. The accuracy and precision of access recirculation measurements by the hemodynamic recirculation monitor. American Journal of Kidney Diseases 31: 242-249.

Lindsay, R.M., P.G. Blake, P. Malek, G. Posen, B. Martin, and E. Bradfield. 1997. Hemodialysis access blood flow rates can be measured by a differential conductivity technique and are predictive of access clotting. American Journal of Kidney Diseases 30: 475-482.

Lindsay, R.M., E. Bradfield, C. Rothera, C. Kianfar, P. Malek, and P.G. Blake. 1998. A comparison of methods for the measurement of hemodialysis access recirculation and access blood flow rate. ASAIO 44: 62-67.

Lloyd, D.A. 1997. On-line evaluation of teaching and courses: The methods, practice, and politics. Advances in Health Sciences Education. A.J.J.A. Scherpier, C.P.M. van der Vleuten, J.J. Rethans, and A.F.W. van der Steeg. Dordrecht: Kluwer Academic Publishers. 330-333.

Strasberg, H., D.A. Lloyd, and T. Ostbye. 1998. Computer usage by medical students. Academic Medicine : 73.

Valberg, L.S., and D.A. Lloyd. 1997. Clinical studies Multimedia program for medical student education in clinical reasoning and the patient-centred clinical method.

Valberg, L.S., and D.A. Lloyd. 1997. Gastrointestinal studies v20 Multimedia program for student and resident education.

Valberg, L.S., and D.A. Lloyd. 1997. Imaging in gastroenterology Multimedia imaging program under development.

Dai, E., M. Stewart, B. Ritchie, N. Mesali, S. Raha, D. Kolodziejczyk, M. Lundstrom Hobman, L.Y. Liu, W. Etches, N. Nation, M. Michalak, and A.R. Lucas. 1997. Calreticulin, a potential vascular regulatory protein, reduceds intimal hyperplasia after arterial injury. Arteriosclerosis, Thrombosis, and Vascular Biology 17: 2307-3363.

Dzavik, V., J.R. Burton, C. Kee, K.K. Teo, A. Ignaszewski, A.R. Lucas, and W.J. Tymchak. 1998. Changing practice patterns in the management of acute myocardial infarction complicated by cardiogenic shock: Elderly compared with younger patients. Canadian Journal of Cardiology 14: 923-930.

Lucas, A.R., E. Dai, L.Y. Liu, M. Perk, R.F. Powers, and P.N. Nation. 1998. A comparison of the effects of an HMG CoA reductase inhibitor and an angiotensin converting enzyme inhibitor in atherosclerotic plaque development after Marek's disease virus infection. Cardiovascular Research 38: 237-246.

Luu, H., E. Dai, M. Mah, L.Y. Liu, P. Nash, G. Abela, G. McFadden, J. Tulip, and A.R. Lucas. 1997. Laser-induced fluorescence (LIF): Detection of changes in atherosclerotic plaque after anti-inflammatory therapy in rabbits. Lasers In Surgery and Medicine (Supp 9): 10.

Chau, L.A., J.A. Bluestone, and J. Madrenas. 1998. Dissociation of intracellular signalling pathways in response to partial agnonist ligands of the T cell receptor. Journal of Experimental Medicine 187: 1699.

Lee, J.E., M.B. Cossoy, L.A. Chau, B. Singh, and J. Madrenas. 1997. Lck Inactivation and Loss of TCR-mediated Signalling uon Persistent Engagement with Complexes of Peptide: MHC Molecules. Journal of Immunology 159: 61.

Madrenas, J., and A.I. Lazarovits. 1998. Differential signaling through the T cell receptor: From biochemistry to transplantation tolerance. Histology and Histopathology 13: 221-229.

Nabavieh, A., H. Chou, I. Volokhov, J.E. Lee, L.E. Purdy, J.F. Elliott, B. Singh, and J. Madrenas. 1998. Development of an I-Ag7-expressing antigen presenting cell line: intrinsic molecular defect in compact I-Ag7 dimer generation. Journal of Autoimmunity 11: 63.

Dupre, J., C.R. Stiller, M. Ghent, A. Donner, B. von Graffenreid, D. Heinrichs, M. Jenner, P.A. Keown, J.L. Mahon, R. Martell, C.I. Momah, G. Murphy, N.W. Rodger, and B.M. Wolfe. 1998. Clinical trials of cyclosporine in IDDM. Diabetes Care 11 (Suppl 1): 37-44.

Edmonds, M., M. Bauer, S. Osborn, H. Lutfiyya, J.L. Mahon, G. Doig, P. Grundy, C. Gittens, G. Molenkamp, and D. Fenlon. 1998. Using the Vista 350 Telephone to Communicate the Results of Home Monitoring of Diabetes Mellitus to a Central Database and to Provide Feedback. International Journal of Medical Informatics 51: 117-125.

Zarnke, K.B., B.G. Feagan, J.L. Mahon, and R.D. Feldman. 1997. A Randomized Study comparing a Patient-directed Hypertension Management Strategy with usual Office-based Care. American Journal of Hypertension 10: 58-67.

Graziadei, I.W., R.H. Wiesner, and P.J. Marotta. 1997. Neoral compared to sandimmune is associated with a decrease in histologic severity of rejection in patients undergoing primary liver transplantation. Transplantation 64: 726-731.

Madala, K., and P.J. Marotta. 1998. Approach to abnormal liver enzymes. Patient Care Canada 9: 33-36.

Marotta, P.J., and E. Roberts. 1998. Pemoline hepatoxicity in children. Journal of Pediatrics 132: 894-897.

Marotta, P.J., R.H. Wiesner, and N.F. LaRusso. 1997. Sclerosing cholangitis. Baillieres Clinical Gastroenterology 11: 781-800.

Chen, L.M., C.M. Martin, S.P. Keenan, and W.J. Sibbald. 1998. Patients readmitted to the Intensive Care Unit during the same hospitalization: Clinical features and outcomes. Critical Care Medicine 26: 1834-1841.

Doig, G., C.M. Martin, and W.J. Sibbald. 1997. Polymyxin-dextran antiendotoxin pretreatment in an ovine model of normotensive sepsis. Critical Care Medicine 25: 1956-1961.

Hebert, P.C., G. Wells, C.M. Martin, M. Tweeddale, J. Marshall, M. Blajchman, D. Sandham, I. Schweitzer, D. Boisvert, and L. Calder. 1998. A Canadian survey of transfusion practices in critically ill patients. Critical Care Medicine 26: 482-487.

Keenan, S.P., P.D. Kernerman, D.J. Cook, C.M. Martin, D.G. McCormack, and W.J. Sibbald. 1997. Effect of noninvasive positive pressure ventilation on mortality in patients admitted with acute respiratory failure: A meta-analysis. Critical Care Medicine 25: 1685-1692.

Martin, C.M., W.J. Sibbald, and R.C. Bone. C.M. Martin, W.J. Sibbald, and R.C. Bone. 1998. Management of Oxygen Delivery in the Critically Ill Patient. Bone's Atlas of Pulmonary and Critical Care Medicine. Philadelphia: Current Medicine, Inc.

Sibbald, W.J., L.M. Chen, and C.M. Martin. 1997. Understanding the ICU business in Europe (Editorial). Intensive Care Medicine 23: 1108-1109.

Sibbald, W.J., C.M. Martin, and R. Piper. 1997. The multiple organ dysfunction syndrome. Sepsis and Multiorgan Failure. R. Bone, E. Abraham, A. Fein, M. Fink, R. Balk, G. Bernard, and D. Dantzker. Philadelphia: Williams and Wilkins.

Sielenkamper, A.W., I.H. Chin-Yee, C.M. Martin, and W.J. Sibbald. 1997. Diaspirin crosslinked hemoglobin improves systemic oxygen uptake in oxygen supply-dependent septic rats. American Journal of Respiratory and Critical Care Medicine 156: 1066-1072.

Keenan, S.P., D. Massel, K.J. Inman, and W.J. Sibbald. 1998. A systematic review of the cost-effectiveness of noncardiac transitional care units. Chest 113: 172-177.

Massel, D. 1997. A comparison of coronary artery stenting with angioplasty for isolated stenosis of the proximal left anterior descending coronary artery (commentary). Annals of Internal Medicine 127: 32.

Massel, D. 1998. Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction (commentary) A quantitative review. Evidence Based Medicine 3: 83.

Massel, D. 1997. Concomitant nitroglycerin and rTPA (letter). American Heart Journal 133: 713-714.

Massel, D. 1997. One year results from the Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries (GUSTO 1) Trial (commentary). Annals of Internal Medicine 126: 3.

Day, J., M. Alexander, M. Drouin, C. Frankish, J. Mazza, D.W. Moote, P. Patel, H. Ramsdale, and W. Yang. 1997. Budesonide Aqueous Nasal Spray and Pressurized Metered Dose Inhaler in the Treatment of Adult Patients with Seasonal Allergic Rhinitis. American Journal of Rhinology 11 (1).

Fischer, D., and J. Mazza. 1997. Four-season allergies. Parkhurst Exchange 5 (8).

Kim, H., D.W. Moote, and J. Mazza. 1997. Tourette's syndrome in patients refererred for allergy evaluation. Annals of Allergy, Asthma & Immunology 79 (Oct.).

Simons, E.F., J. Mazza, D.W. Moote, et al. 1997. A comparison of beclomethasone, salmeterol and placebo in children with asthma. New England Journal of Medicine 337 (Dec.): 1659-1665.

Bauld, D.B., W.A. McCauley, J.B. Brown, and M.A. Stuart. 1998. The Patient-Centred Method in the Emergency Department: Assessing its Impact on Patient Perception. Journal of Emergency Medicine 16 (2): 382-383.

Gerace, R.V., and W.A. McCauley. 1997. Emergency Medicine: Progress, Frustation and Controversy. Canadian Medical Association Journal 157: 1683-1684.

Gerace, R.V., W.A. McCauley, and E.F. Wijdicks. 1998. Emergency Management of the Comatose Patient. Coma and Impaired Consciousness: A Clinical Perspective. G.B. Young, A.H. Ropper, and C.F. Bolton. New York: McGraw-Hill. 563-578.

McCauley, W.A. 1998. Caring for Patients in A Rural Environment. Canadian Journal of Continuing Medical Education 10 (1): 47-64.

McCauley, W.A. 1998. Respiratory Failure: Diagnosis, Drugs and Machines. Journal of Emergency Medicine 16 (2): 329-330.

Keenan, S.P., P.D. Kernerman, D.J. Cook, C.M. Martin, D.G. McCormack, and W.J. Sibbald. 1997. Effect of noninvasive positive pressure ventilation on mortality in patients admitted with acute respiratory failure: A meta-analysis. Critical Care Medicine 25: 1685-1692.

Tyml, K., J. Yu, and D.G. McCormack. 1998. Capillary and arteriolar responses to local vasodilators are impaired in a rat model of sepsis. Journal of Applied Physiology 84: 837-844.

Gregor, J.C., J.W.D. McDonald, N. Klar, R. Wall, K. Atkinson, B. Lamba, and B.G. Feagan. 1997. An evaluation of utility measurements in Crohn's disease. Inflammatory Bowel Disease 3 (4): 265-276.

Anvari, M., C.A. Paterson, E.E. Daniel, and T.J. McDonald. 1998. Effects of GLP-1 on gastric emptying, antropyloric motility and transpyloric flow in response to a non-nutrient liquid. Digestive Diseases and Sciences 43 (6): 1133-1140.

Kong, C., B.M. Gill, R. Rahimpour, L. Xu, R.D. Feldman, Q. Xiao, T.J. McDonald, L. Taupenot, S.K. Mahata, B. Singh, O, D.T. Connor, and D.J. Kelvin. 1998. Secretoneurin and chemoattractant receptor interactions. Journal of Neuroimmunology 88: 91-98.

Mao, Y.K., Y.F. Wang, C. Moogk, J.E.T. Fox-Threlkeld, Q. Xiao, T.J. McDonald, and E.E. Daniel. 1998. Locations and molecular forms of PACAP, and sites and characteristics of PACAP receptors in canine ileum. American Journal of Physiology 274: G217-G225.

Petrik, J., E. Arany, T.J. McDonald, and D.J. Hill. 1998. Apoptosis in the pancreatic islet cells of the neonatal rat is associated with a reduced expression of insulin-like growth factor-II which may act as a survival factor. Endocrinology 139: 2994-3004.

Wang, Y.F., Y.K. Mao, J.E.T. Fox-Threlkeld, T.J. McDonald, and E.E. Daniel. 1998. Colocalization of inhibitory mediators, NO, VIP and galanin in canine enteric nerves. Peptides 19: 99-112.

Xiao, Q., X. Han, E. Arany, D.J. Hill, J.R.G. Challis, and T.J. McDonald. 1998. Human placenta and fetal membranes contain peptide YY1-36 and peptide YY3-36. Journal of Endocrinology 156: 485-492.

McFadden, R.G. 1998. When your patient can't stop coughing. Canadian Journal of Continuing Medical Education 10: 117-125.

Tsai, W.H., and R.G. McFadden. 1997. Pulmonary disease in the pregnant patient. Canadian Journal of Diagnosis 14: 57-65.

McManus, R. 1997. Insulin: Past, Present and Future. Diabetes London 32 (1).

De Sanctis, G.T., S. Mehta, L. Kobzik, C. Yandava, A. Jiao, P.L. Huang, and J.M. Drazen. 1997. Contribution of type I NOS to expired NO and bronchial responsiveness in mice. American Journal of Physiology 273: L883-L888.

Mehta, S., J.M. Drazen, and C.M. Lilly. 1997. Endogenous nitric oxide and allergic bronchial hyperresponsiveness in guinea pigs. American Journal of Physiology 273: L656-L662.

Finnie, K.J.C., and L.J. Melendez. 1997. Backwards or forwards? Canadian Journal of Diagnosis 14: 29-30.

Finnie, K.J.C., and L.J. Melendez. 1998. Changing Relationships. Canadian Journal of Diagnosis 15: 45-46.

Finnie, K.J.C., and L.J. Melendez. 1997. How many do you see? Canadian Journal of Diagnosis 14: 31-32.

Finnie, K.J.C., and L.J. Melendez. 1997. Massaging the block. Canadian Journal of Diagnosis 14: 33-34.

Finnie, K.J.C., and L.J. Melendez. 1998. A slow pace. Canadian Journal of Diagnosis 15: 35-36.

Finnie, K.J.C., and L.J. Melendez. 1998. The Swinging Heart. Canadian Journal of Diagnosis 15: 61-62.

Melendez, L.J., and K.J.C. Finnie. 1998. Is that right? Canadian Journal of Diagnosis 15: 37-38.

Melendez, L.J., and K.J.C. Finnie. 1998. Man with chest pain. Canadian Journal of Diagnosis 15: 33-34.

Melendez, L.J., and K.J.C. Finnie. 1997. An other side story. Canadian Journal of Diagnosis 14: 31-33.

Melendez, L.J., and K.J.C. Finnie. 1997. Perioperative trouble? Canadian Journal of Diagnosis 14: 31-32.

Melendez, L.J., and K.J.C. Finnie. 1997. Summer road blocks. Canadian Journal of Diagnosis 14: 29-30.

Melendez, L.J., and K.J.C. Finnie. 1998. Which one will get there first? Canadian Journal of Diagnosis 15: 57-58.

Clark, W.F., and L. Moist. 1998. Management of chronic renal insufficiency in lupus nephritis: Role of proteinuria, hypertension and dyslipidemia in the progression of renal disease. Lupus.

Moist, L., G. Nesrallah, C. Kortas, E. Ispiritu, T. Ostbye, and W.F. Clark. 1998. Plasma exchange in rapidly progressive renal failure due to multiple myeloma. American Journal of Nephrology.

Day, J., M. Alexander, M. Drouin, C. Frankish, J. Mazza, D.W. Moote, P. Patel, H. Ramsdale, and W. Yang. 1997. Budesonide Aqueous Nasal Spray and Pressurized Metered Dose Inhaler in the Treatment of Adult Patients with Seasonal Allergic Rhinitis. American Journal of Rhinology 11 (1).

Kim, H., D.W. Moote, and J. Mazza. 1997. Tourette's syndrome in patients refererred for allergy evaluation. Annals of Allergy, Asthma & Immunology 79 (Oct.).

Simons, E.F., J. Mazza, D.W. Moote, et al. 1997. A comparison of beclomethasone, salmeterol and placebo in children with asthma. New England Journal of Medicine 337 (Dec.): 1659-1665.

Muirhead, N. 1997. The clinical impact of recombinant human erythropoietin. Journal of the Royal College of Physicians of London 13: 125-148.

Nielson, W.R., M. Harth, and D.A. Bell. 1997. Out-Patient cognitive-behavioural treatment of fibromyalgia: Impact on pain response and health status. Pain Research Management 2: 145-150.

Paterson, N.A.M. 1997. Editorial summary: Epidemiology. J Club - Asthma 1: 4-5.

Paterson, N.A.M. 1997. Editorial summary: Exercise-induced asthma. J Club - Asthma 1: 6-7.

Paterson, N.A.M. 1997. Editorial summary: Inflammation and inflammatory mediators. J Club - Asthma 1: 8-9.

Paterson, N.A.M. 1997. Editorial summary: Leukoriene anagonist therapy. J Club - Asthma 1: 10-11.

Paterson, N.A.M. 1997. Editorial summary: Quality of life. J Club - Asthma 1: 12-13.

Patrick, L.T. 1998. Development and Validation of a New Perioperative Cardiac Risk Index for Patients Undergoing Non-Cardiac Surgery. SGIM Abstract (April).

Vingilis, E., U. Brown, R. Koeppen, B. Hennen, M. Bass, K. Payton, J. Downe, and M. Stewart. 1997. Evaluation of a cold/flu self-care public education campaign. Health Education Research Theory and Practice 12.

Kandaker, M., L. Xu, R. Rahimpour, B. Gill, G. Mitchel, M.E. Devries, S.K. Sinhal, J.G. Pickering, R.D. Feldman, and D.J. Kelvin. 1998. CXCR1 and CXCR2 are rapidy down-modulated by bacterial endotoxin through a unique agonist-independent, tyrosine kinase-dependent mechanism. Journal of Immunology 161: 1930-1938.

Rocnik, E., B.M.C. Chan, and J.G. Pickering. 1998. Evidence for a role of collagen synthesis in arterial smooth muscle cell migration. Journal of Clinical Investigation 101: 1889-1898.

Bellamy, N., S. Kaloni, J. Pope, W.K. Coulter, and J. Campbell. 1998. Quantitative rheumatology: A survey of outcome measurement procedures in routine rheumatology outpatient practice in Canada. Journal of Rheumatology 25: 852-858.

Joneja, M., and J. Pope. 1998. Systemic lupus erythematosus: What tests should you use? Canadian Journal of Diagnosis 15 (6): 99-103.

Pope, J. 1998. The hidden benefits of hydroxycloroquine. Journal of the Canadian Rheumatology Association 8: 8-9.

Pope, J., A. Stevens, W. Howson, and D.A. Bell. 1998. The development of RA following recombinant Hepatitis B vaccination. Journal of Rheumatology 25: 1687-1693.

Driman, D.K., and H.G. Preiksaitis. 1998. Colorectal inflammation and increased cell proliferation associated with oral sodium phosphate bowel preparation solution. Human Pathology 29: 972-978.

Preiksaitis, H.G. 1998. Helicobacter pylori and gastroesophageal reflux disease. Research Forum, Selected Proceedings Highlights with a Primary Care Perspective. Solvay Pharma Inc. and Byk Canada.

Preiksaitis, H.G. 1998. Pharmacological and molecular characterization of muscarinic receptors in cat esophageal smooth muscle. Journal of Pharmacology and Experimental Therapeutics 285: 853-861.

Preiksaitis, H.G., and L.G. Laurier. 1998. Pharmacological and molecular characterization of muscarinic receptors in cat espophageal smooth muscle. Journal of Pharmacology and Experimental Therapeutics 285: 853-861.

Sims, S.M., Y. Jiao, and H.G. Preiksaitis. 1997. Regulation of intracellular calcium in human esophageal smooth muscle. American Journal of Physiology 273 (42): C1679-C1689.

Stal, J., J.C. Gregor, H.G. Preiksaitis, and R.P.E. Reynolds. 1998. A cost-utility analysis comparing omeprazole with ranitidine in the maintenance therapy of peptic esophageal stricture. Canadian Journal of Gastroenterology 12: 43-49.

Atkinson, K., and I. Prokopiw. 1998. Acute airway obstruction from insertion of a cuffed esophageal stent for malignant tracheoesophageal fistula. Gastrointestinal Endoscopy 47: 416-417.

Couroux, P.R., Z. Hussain, F.S. Rutledge, R. Lannigan, E.D. Ralph, B. Nancekivell, and T.W. Austin. 1997. Polymerase chain reaction and RNA hybridization-based method for the investigation of deep-seated candidiasis. Canadian Journal of Infectious Diseases 8: 329-334.

Ralph, E.D., and R.B. Bourne. 1998. Toxic shock syndrome in association with a group A streptococcal infection of a knee joint with a total knee arthroplasty. Journal of Bone and Joint Surgery 80A: 96-98.

Beck, I.T., M.C. Champion, S. Lemire, A.B.R. Thompson, R.P.E. Reynolds, et al. 1997. The Second Canadian Consensus Conference on the Management of Patients with Gastroesophageal Reflux Disease. Canadian Journal of Gastroenterology 11 (SUPPL B): 7B-20B.

Reynolds, R.P.E. 1997. Pathophysiology and investigation of Barrett's esophagus. Canadian Journal of Gastroenterology 11 (SUPPL B): 41B-44B.

Stal, J., J.C. Gregor, H.G. Preiksaitis, and R.P.E. Reynolds. 1998. A cost-utility analysis comparing omeprazole with ranitidine in the maintenance therapy of peptic esophageal stricture. Canadian Journal of Gastroenterology 12: 43-49.

Dupre, J., C.R. Stiller, M. Ghent, A. Donner, B. von Graffenreid, D. Heinrichs, M. Jenner, P.A. Keown, J.L. Mahon, R. Martell, C.I. Momah, G. Murphy, N.W. Rodger, and B.M. Wolfe. 1998. Clinical trials of cyclosporine in IDDM. Diabetes Care 11 (Suppl 1): 37-44.

Hernandez, C.A., G.I. Bradish, H.K.S. Laschinger, N.W. Rodger, and S.I. Rybansky. 1997. Self-awareness work in Type I Diabetes: Traversing experience and negotiating collaboration. Canadian Journal of Diabetes Care 21: 21-27.

Wolever, T.M.S., J.-L. Chiasson, R.G. Josse, J.A. Hunt, C. Palmason, N.W. Rodger, S.A. Stewart, E.A. Ryan, and M.H. Tan. 1997. Small weight loss on long term acarbose therapy with no change in dietary pattern or nutrient intake of individuals with non-insulin dependent diabetes. International Journal of Obesity 21: 756-763.

Cook, D.J., P.C. Hebert, D.K. Heyland, G.H. Guyatt, C. Brun-Buisson, J.C. Marshall, J.L. Vincent, J. Russell, C.L. Sprung, F.S. Rutledge, and The Evidence-Based Critical Care Medicine Group. 1997. How to use an article on therapy or prevention: Pneumonia prevention using subglottic secretion drainage. Critical Care Medicine 25: 1502-1513.

Cook, D., G. Guyatt, J. Marshall, D.J. Leasa, H. Fuller, R. Hall, S. Peters, F.S. Rutledge, L. Griffith, A. McLellan, G. Wood, and A.S. Kirby. 1998. A comparison of sucralfate and ranitidine for the prevention of upper gastrointestinal bleeding in patients requiring mechanical ventilation. New England Journal of Medicine 338 (12): 791-797.

Couroux, P.R., Z. Hussain, F.S. Rutledge, R. Lannigan, E.D. Ralph, B. Nancekivell, and T.W. Austin. 1997. Polymerase chain reaction and RNA hybridization-based method for the investigation of deep-seated candidiasis. Canadian Journal of Infectious Diseases 8: 329-334.

Inman, K., B. Davidson, W.J. Sibbald, and F.S. Rutledge. 1998. Closed enteral systems in the Intensive Care Unit: Evaluating their economic impact. Nutrition in Clinical Practice 13: S42-S45.

Rutledge, F.S., and D.J. Leasa. 1998. Acute respiratory failure. Bone's Atlas of Pulmonary and Critical Care Medicine. R.C. Bone, G.D. Campbell, D. Payne, A.C. Arroliga, R.B. George, L.J. Goodman, and W.J. Sibbald. Philadelphia: Williams & Wilkins. 24.01-24.11.

Feldman, R.D., N.D. Schmidt, and K.B. Zarnke. 1998. Angiotensin-converting enzyme inhibitor-mediated regulation of vasodilator function. Canadian Journal of Cardiology 14 (Suppl D): 19D-20D.

Darrah, W.C., M.D. Sharpe, G. Guiraudon, and A. Neal. 1997. Intra-aortic balloon counterpulsation improves right ventricular failure from pressure overload. Annals of Thoracic Surgery 64: 1718-1724.

Bone, R.C., G.D. Campbell, D.K. Payne, A.C. Arroliga, R.B. George, L.J. Goodman, and W.J. Sibbald. 1998. Bone's Atlas of Pulmonary and Critical Care Medicine. Williams and Wilkins.

Chen, L.M., C.M. Martin, S.P. Keenan, and W.J. Sibbald. 1998. Patients readmitted to the Intensive Care Unit during the same hospitalization: Clinical features and outcomes. Critical Care Medicine 26: 1834-1841.

d'Almeida, M.S., W.J. Sibbald, M. White, and I.H. Chin-Yee. 1998. Influence of sepsis on the plasma elimination pharmokinetics of diaspirin cross-linked hemoglobin in rats. Artificial Cells, Blood Substitutes and Immobilization Biotechnology 26

Doig, G., C.M. Martin, and W.J. Sibbald. 1997. Polymyxin-dextran antiendotoxin pretreatment in an ovine model of normotensive sepsis. Critical Care Medicine 25: 1956-1961.

Inman, K., B. Davidson, W.J. Sibbald, and F.S. Rutledge. 1998. Closed enteral systems in the Intensive Care Unit: Evaluating their economic impact. Nutrition in Clinical Practice 13: S42-S45.

Keenan, S.P., K.D. Busche, L.M. Chen, R. Esmail, W.J. Sibbald, and K.J. Inman. 1998. The withdrawal and withholding of life support in the Intensive Care Unit: A comparison between teaching and community hospitals. Critical Care Medicine 26: 245-261.

Keenan, S.P., P.D. Kernerman, D.J. Cook, C.M. Martin, D.G. McCormack, and W.J. Sibbald. 1997. Effect of noninvasive positive pressure ventilation on mortality in patients admitted with acute respiratory failure: A meta-analysis. Critical Care Medicine 25: 1685-1692.

Keenan, S.P., D. Massel, K.J. Inman, and W.J. Sibbald. 1998. A systematic review of the cost-effectiveness of noncardiac transitional care units. Chest 113: 172-177.

Marshall, J.C., N.V. Christou, and W.J. Sibbald. 1997. Sepsis, SIRS and MODS: A Canadian Perspective. Intensive Care World 14: 94-96.

Martin, C.M., W.J. Sibbald, and R.C. Bone. C.M. Martin, W.J. Sibbald, and R.C. Bone. 1998. Management of Oxygen Delivery in the Critically Ill Patient. Bone's Atlas of Pulmonary and Critical Care Medicine. Philadelphia: Current Medicine, Inc.

Pang, D., S.P. Keenan, D.J. Cook, and W.J. Sibbald. 1998. The effect of positive airway support on mortality and the need for intubation in cardiogenic pulmonary edema: A systematic review. Chest 114: 1185-1182.

Piper, R.D., M. Pitt-Hyde, L.A. Anderson, W.J. Sibbald, and R.D. Potter. 1998. Leukocyte activation and flow behaviour in rat skeletal muscle in sepsis. American Journal of Respiratory and Critical Care Medicine 157: 129-134.

Piper, R., F.U. Li, M.L. Myers, and W.J. Sibbald. 1997. Structure function relationships in the septic rat heart. American Journal of Respiratory and Critical Care Medicine 156: 1473-1482.

Rotandi, A.J., V. Kvetan, J. Carlet, and W.J. Sibbald. 1997. Consensus conferences in Critical Care Medicine: Methodologies and impact. Critical Care Clinics 13: 417-439.

Sibbald, W.J. 1997. Executive Summary of an American College of Chest Physicians, National Institute of Allergy and Infectious Disease, and National Heart, Lung and Blood Institute Workshop From the bench to the bedside. Chest 111: 744-753.

Sibbald, W.J. 1998. "In Consultation" response on pursuing a sepsis diagnosis when initial results are negative. Journal of Critical Illness 13 (5): 280.

Sibbald, W.J. 1998. Some opinions on the future of evidence-based medicine. Critical Care Clinics. D. Cook, and M. Levy. New Jersey: W.B. Saunders Company.

Sibbald, W.J., L.M. Chen, and C.M. Martin. 1997. Understanding the ICU business in Europe (Editorial). Intensive Care Medicine 23: 1108-1109.

Sibbald, W.J., and S.P. Keenan. 1997. Show me the evidence: A critical appraisal of the pulmonary artery consensus conference and other musings on how critical care practitioners need to improve the way we conduct business. Critical Care Medicine 25: 2060-2063.

Sibbald, W.J., and J.D. Kossuth. 1998. The Ontario Health Evaluation Network and the Critical Care Research Network as vehicles for research transfer. Medical Decision Making 18: 9-16.

Sibbald, W.J., C.M. Martin, and R. Piper. 1997. The multiple organ dysfunction syndrome. Sepsis and Multiorgan Failure. R. Bone, E. Abraham, A. Fein, M. Fink, R. Balk, G. Bernard, and D. Dantzker. Philadelphia: Williams and Wilkins.

Sibbald, W.J., and T.J. Singh. 1997. Critical Care in Canada: The North American Difference. Critical Care Clinics. V. Kvetan, J.L. Vincent, and G.J. Dobb. New Jersey: W.B. Saunders Company.

Sielenkamper, A.W., I.H. Chin-Yee, C.M. Martin, and W.J. Sibbald. 1997. Diaspirin crosslinked hemoglobin improves systemic oxygen uptake in oxygen supply-dependent septic rats. American Journal of Respiratory and Critical Care Medicine 156: 1066-1072.

Badner, N.H., K. Drader, D.J. Freeman, and J.D. Spence. 1998. The Use of Intra-operative Nitrous Oxide Leads to Postooperative Increases in Plasma Homocysteine. Anesthesia and Analgesia 87: 711-713.

Bailey, D.G., J.M.O. Arnold, and J.D. Spence. 1998. Grapefruit juice: Drug interactions. British Journal of Clinical Pharmacology 46: 101-110.

Bailey, D.G., J.M.O. Arnold, and J.D. Spence. 1998. Grapefruit juice-drug interactions (Review). British Journal of Clinical Pharmacology 45: 101-110.

Thompson, J.M., and W. Ainslei. (1998). The Screening Musculoskeletal Examination . (Booklet) .

Boulet, L.-P., D.W. Cockcroft, J.H. Toogood, Y. Lacasse, J. Baskerville, and F.E. Hargreave. 1998. Comparative assessment of safety and efficacy of inhaled corticosteroids: report of a Committee of the Canadian Thoracic Society. European Respiratory Journal 11: 1194-1210.

Toogood, J.H. 1998. Asthma management to limit the risk of steroid osteoporosis. Canadian Journal of Allergy and Clinical Immunology 3 (2): 68-74.

Toogood, J.H. 1998. Effects of inhaled steroids on bone. Journal of Respiratory Diseases 19 (6): 480-492.

Toogood, J.H. 1998. Inhaled steroid asthma treatment: "Primum Non Nocere". Canadian Respiratory Journal 5 (A): 50A-53A.

Gross, N.J., R.A.W. Veldhuizen, F. Possmayer, and R. Dhand. 1997. Surfactant convertase action is not essential for surfactant film formation. American Journal of Physiology 273: L907-L912.

Ito, Y., S.E.E. Manwell, C.L. Kerr, R.A.W. Veldhuizen, L.-J. Yao, D. Bjarneson, L.A. McCaig, A.J. Barlett, and J.F. Lewis. 1998. Effects of ventilation strategies on the efficacy of exogenous surfactant therapy in a rabbit model of acute lung injury. American Journal of Respiratory and Critical Care Medicine 157: 149-155.

Ito, Y., R.A.W. Veldhuizen, L. Yao, L. McCaig, A. Bartlett, and J.F. Lewis. 1997. Ventilation strateies affect surfactant aggregate conversion in acute lung injury. American Journal of Respiratory and Critical Care Medicine 155: 493-499.

Kerr, C.L., Y. Ito, S.E.E. Manwell, R.A.W. Veldhuizen, L.-J. Yao, L.A. McCaig, and J.F. Lewis. 1998. Effects of surfactant distribution and ventilation strategies on efficacy of exogenous surfactant. Journal of Applied Physiology 85: 676-685.

Malloy, J., L. McCaig, R.A.W. Veldhuizen, L. Yao, J. Whitsett, M. Joseph, and J.F. Lewis. 1997. Alterations of the endogenous surfactant system in septic adult rats. American Journal of Respiratory and Critical Care Medicine 156: 617-623.

Novick, R.J., A.A. Gilpin, K.E. Gehman, I.S. Ali, R.A.W. Veldhuizen, J. Duplan, L. Denning, F. Possmayer, D. Bjarneson, and J.F. Lewis. 1997. Mitigation of injury in canine lung grafts by exogenous surfactant. Journal of Thoracic and Cardiovascular Surgery 113: 342-353.

Possmayer, F., R.J. Novick, R.A.W. Veldhuizen, J. Lee, D. Bjarneson, and J.F. Lewis. 1998. Potential role for pulmonary surfactant in lung transplantation. Acute Respiratory Distress Syndrome: Cellular and Molecular Mechanisms and Clinical Management. S. Matalon, and J.I. Szajder. New York: Plenum Press. 117-124.

Vanderzwan, J., R.A.W. Veldhuizen, and J.F. Lewis. 1998. A current and future perspective of exogenous surfactant therapy for acute respiratory distress syndrome. Current Opinions in Critical Care Medicine 4: 21-27.

Veldhuizen, R.A.W., Y. Ito, J. Marcou, L.-J. Yao, L. McCaig, and J.F. Lewis. 1997. Effects of lung injury on pulmonary surfactant aggregate conversion in vivo and in vitro. American Journal of Physiology 272: L872-L878.

Wells, J.L. 1998. Geriatric education: Bridging the gap. Mature Medicine Canada 1 (1): 36-37.

Wexler, D. 1998. Treatment Choice. The London and District Academy Newsletter (March).

Wexler, D., and N. Shear. 1998. Point-Counterpoint - Antihistamines and the Risks They Pose. Journal of Cutaneous Medicine and Surgery 3 (1).

Dupre, J., C.R. Stiller, M. Ghent, A. Donner, B. von Graffenreid, D. Heinrichs, M. Jenner, P.A. Keown, J.L. Mahon, R. Martell, C.I. Momah, G. Murphy, N.W. Rodger, and B.M. Wolfe. 1998. Clinical trials of cyclosporine in IDDM. Diabetes Care 11 (Suppl 1): 37-44.

Whitman, S.C., D.B. Miller, B.M. Wolfe, and M.W. Huff. 1998. Oxidized type IV hypertriglyceridemic VLDL-remnants are more atherogenic than oxidized LDL. Journal of Lipid Research 39: 1008-1020.

Wolfe, B.M., J.J. Kovak, and J.A. Nisker. 1998. Effects of adding lower dosage C-19 versus C-21 progestin to conjugated estrogen in moderately hypercholesterolemic postmenopausal women. American Journal of Obstetrics and Gynecology 178: 787-792.

Basta, M., G.J. Klein, R. Yee, A.D. Krahn, and J. Lee. 1997. Current role of pharmacologic therapy for patients with paroxysmal supraventicular tachycardia. Cardiology Clinics 15 (4): 587-597.

Guiraudon, G.M., C.M. Guiraudon, G.J. Klein, and R. Yee. 1998. Atrial fibrillation: Functional anatomy and surgical rationales. Ten years of radiofrequency catheter ablation. C. Moro, and J. Farre. Armonk, NY: Futura Publishing Co. 289-310.

Guiraudon, G.M., C.M. Guiraudon, G.J. Klein, R. Yee, and A.D. Krahn. 1998. Surgical anatomy of the atrio-ventricular junction. Ten Years of Radiofrequency Catheter Ablation. C. Moro, and J. Farre. Armonk, NY: Futura Publishing Co., Inc. 59-73.

Guiraudon, G.M., G.J. Klein, C.M. Guiraudon, and R. Yee. 1998. Surgical approaches to supraventricular tachycardia. Nonpharmacological Therapy of Arrhythmias for the 21st Century: The State of the Art. I. Singer, S.S. Barold, and A.J. Camm. Armonk, NY: Futura Publishing. 631-652.

Guiraudon, G.M., G.J. Klein, C.M. Guiraudon, and R. Yee. 1998. Surgical treatment of atrial fibrillation: What's new? Atrial Flutter and Fibrillation: From Basic to Clinical Applications. N. Saoudi, W. Schoels, and N. El-Sherif. Armonk, NY: Futura Publishing Company, Inc. 349-360.

Guiraudon, G.M., G.J. Klein, R. Yee, and D. Switzer. 1998. Surgical treatment of ventricular tachycardias. Nonpharmacological Therapy of Arrhythmias for the 21st Century: The State of the Art. I. Singer, S.S. Barold, and A.J. Camm. Armonk, NY: Futura Publishing Co, Inc. 667-683.

Krahn, A.D., G.J. Klein, and R. Yee. 1998. The approach to the athlete with Wolff Parkinson White Syndrome: Risk of sudden cardiac death. Sudden Cardiac Death in the Athlete. N.A.M. Estes, D.N. Salem, and P.J. Wang. Armonk, NY: Futura Publishing Co., Inc. 237-252.

Krahn, A.D., G.J. Klein, and R. Yee. 1997. Hysteresis of the RT interval with exercise: A new marker for the long QT syndrome. Circulation 96: 1551-1556.

Krahn, A.D., G.J. Klein, and R. Yee. 1997. Perfecting your clinical approach to syncope. Perspectives in Cardiology 13: 27-42.

Krahn, A.D., G.J. Klein, and R. Yee. 1998. Pushing the ablation frontier in atrioventricular node reentrant tachycardia. European Heart Journal 19: 828-829.

Krahn, A.D., G.J. Klein, and R. Yee. 1997. Recurrent Syncope: Experience with an Implantable Loop Recorder. Cardiology Clinics: Syncope 15 (2): 13-26.

Krahn, A.D., G.J. Klein, and R. Yee. 1998. Recurrent unexplained syncope in a 69 year old man. Cardiac Electrophysiology Monthly 1: 35-37.

Krahn, A.D., G.J. Klein, and R. Yee. 1997. Recurrent unexplained syncope: When all else fails. Syncope: Mechanisms and management. B.P. Grubb, and B. Olansky. Armonk, NY: Futura Publishing Co. 359-369.

Krahn, A.D., G.J. Klein, R. Yee, M.N. Basta, and J.K. Lee. 1997. Progressive anterior ablation in the coronary sinus region: Evidence to support the presence of a slow pathway in normal patients. Circulation 96: 3477-3483.

Krahn, A.D., G.J. Klein, R. Yee, and C. Norris. 1998. Final results from a pilot study with an implantable loop recorder to determine the etiology of syncope in patients with negative noninvasive and invasive testing. American Journal of Cardiology 82: 117-119.

Lee, J.K., R. Yee, G.J. Klein, A.D. Krahn, and M.N. Basta. 1997. Electrophysiology studies in the assessment and management of patients involved in high risk occupations and activities. Cardiac EP Reviews 4: 473-477.

Li, H., R. Yee, R.K. Thakur, and G.J. Klein. 1997. The effect of variable retrograde penetration on dual AV nodal pathways: Observations before and after slow pathway ablation LDD. PACE 20: 2146-2153.

Simpson, C.S., M.A. Fisher, M.J. Curtis, A.D. Krahn, H. Abdollah, S.R. Raj, F.J. Brennan, G.J. Klein, and R. Yee. 1998. Correlation of waiting time with adverse events in patients admitted for nonelective permanent pacemaker implantation. Canadian Journal of Cardiology 14 (6): 817-821.

Dresser, G., and K.B. Zarnke. 1998. http://wwwhypertension: Information Overload and Serendipity on the Net. Hypertension Canada 58

Feldman, R.D., N.D. Schmidt, and K.B. Zarnke. 1998. Angiotensin-converting enzyme inhibitor-mediated regulation of vasodilator function. Canadian Journal of Cardiology 14 (Suppl D): 19D-20D.

Zarnke, K.B. 1998. The conduct of health economic evaluations: A focus on hypertension. Topics in Cardiovascular Health Economics 1: 8-11.

Zarnke, K.B., B.G. Feagan, J.L. Mahon, and R.D. Feldman. 1997. A Randomized Study comparing a Patient-directed Hypertension Management Strategy with usual Office-based Care. American Journal of Hypertension 10: 58-67.

Zarnke, K.B., M.A.H. Levine, and B.J. O'Brien. 1997. Cost-benefit analyses in the health care literature: Don't judge a study by its label. Journal of Clinical Epidemiology 50: 813-822.